{"id":41230,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/purchase-agreement-notes-digital-river-inc.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"purchase-agreement-notes-digital-river-inc","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/finance\/purchase-agreement-notes-digital-river-inc.html","title":{"rendered":"Purchase Agreement &#8211; Notes &#8211; Digital River Inc."},"content":{"rendered":"<p align=\"center\"><strong>$300,000,000<\/strong><\/p>\n<p align=\"center\">\n<p align=\"center\"><strong>DIGITAL RIVER, INC.<\/strong><\/p>\n<p align=\"center\">\n<p align=\"center\"><strong>2.00% CONVERTIBLE SENIOR NOTES DUE 2030 <br \/>\nCOMMON STOCK, PAR VALUE $0.01<\/strong><\/p>\n<p align=\"center\">\n<p align=\"center\"><strong>PURCHASE AGREEMENT<\/strong><\/p>\n<p align=\"center\">\n<p>October 26, 2010<\/p>\n<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr>\n<p>size=2 width=&#8221;100%&#8221; noshade style=&#8217;color:#A0A0A0&#8242; align=center&gt;<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"right\">October 26, 2010<\/p>\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated<br \/>\nMorgan Stanley &amp; Co. Incorporated<\/p>\n<p>As Representatives of the several Initial Purchasers named in Schedule I<br \/>\nhereto<\/p>\n<p>c\/o Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated<br \/>\nOne Bryant Park<br \/>\nNew York, NY 10036<\/p>\n<p>c\/o Morgan Stanley &amp; Co. Incorporated<br \/>\n1585 Broadway<br \/>\nNew York, NY 10036<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>Digital River, Inc., a Delaware corporation (the<br \/>\n&#8220;<strong>Company<\/strong>&#8220;), proposes to issue and sell to the several<br \/>\npurchasers named in Schedule I hereto (the &#8220;<strong>Initial<br \/>\nPurchasers<\/strong>&#8220;), for whom you are acting as representatives (the<br \/>\n&#8220;<strong>Representatives<\/strong>&#8220;), $300,000,000 principal amount of its 2.00%<br \/>\nConvertible Senior Notes due 2030 (the &#8220;<strong>Firm Securities<\/strong>&#8220;) to be<br \/>\nissued pursuant to the provisions of an Indenture dated as of the Closing Date<br \/>\n(as defined in Section 4) (the &#8220;<strong>Indenture<\/strong>&#8220;) between the Company<br \/>\nand Wells Fargo Bank, National Association, as Trustee (the<br \/>\n&#8220;<strong>Trustee<\/strong>&#8220;). The Company also proposes to issue and sell to the<br \/>\nInitial Purchasers not more than an additional $45,000,000 principal amount of<br \/>\nits 2.00% Convertible Senior Notes due 2030 (the &#8220;<strong>Additional<br \/>\nSecurities<\/strong>&#8220;) if and to the extent that you, as Representatives of the<br \/>\noffering, shall have determined to exercise, on behalf of the Initial<br \/>\nPurchasers, the right to purchase such 2.00% Convertible Senior Notes due 2030<br \/>\ngranted to the Initial Purchasers in Section 2 hereof. The Firm Securities and<br \/>\nthe Additional Securities are hereinafter collectively referred to as the<br \/>\n&#8220;<strong>Securities<\/strong>&#8220;. The Securities will be convertible into shares of<br \/>\ncommon stock, par value $0.01, of the Company (the &#8220;<strong>Underlying<br \/>\nSecurities<\/strong>&#8220;).<\/p>\n<p>The Securities and the Underlying Securities will be offered without being<br \/>\nregistered under the Securities Act of 1933, as amended (the<br \/>\n&#8220;<strong>Securities Act<\/strong>&#8220;), to qualified institutional buyers in<br \/>\ncompliance with the exemption from registration provided by Rule 144A under the<br \/>\nSecurities Act.<\/p>\n<p>In connection with the sale of the Securities, the Company has prepared a<br \/>\npreliminary offering memorandum (the &#8220;<strong>Preliminary Memorandum<\/strong>&#8220;)<br \/>\nand will prepare a final offering memorandum (the &#8220;<strong>Final<br \/>\nMemorandum<\/strong>&#8220;) including or incorporating by reference a description of<br \/>\nthe terms of the Securities and the<\/p>\n<hr>\n<p>size=2 width=&#8221;100%&#8221; noshade style=&#8217;color:#A0A0A0&#8242; align=center&gt;<\/p>\n<p>Underlying Securities, the terms of the offering and a description of the<br \/>\nCompany. For purposes of this Agreement, &#8220;<strong>Additional Written Offering<br \/>\nCommunication<\/strong>&#8221; means any written communication (as defined in Rule 405<br \/>\nunder the Securities Act) that constitutes an offer to sell or a solicitation of<br \/>\nan offer to buy the Securities other than the Preliminary Memorandum or the<br \/>\nFinal Memorandum, and &#8220;<strong>Time of Sale Memorandum<\/strong>&#8221; means the<br \/>\nPreliminary Memorandum together with the Additional Written Offering<br \/>\nCommunications, if any, each identified in Schedule III hereto. As used herein,<br \/>\nthe terms Preliminary Memorandum, Time of Sale Memorandum and Final Memorandum<br \/>\nshall include the documents, if any, incorporated by reference therein. The<br \/>\nterms &#8220;<strong>supplement<\/strong>&#8220;, &#8220;<strong>amendment<\/strong>&#8221; and<br \/>\n&#8220;<strong>amend<\/strong>&#8221; as used herein with respect to the Preliminary<br \/>\nMemorandum, the Time of Sale Memorandum, the Final Memorandum or any Additional<br \/>\nWritten Offering Communication shall include all documents subsequently filed by<br \/>\nthe Company with the Securities and Exchange Commission (the<br \/>\n&#8220;<strong>Commission<\/strong>&#8220;) pursuant to the Securities Exchange Act of 1934,<br \/>\nas amended (the &#8220;<strong>Exchange Act<\/strong>&#8220;), that are deemed to be<br \/>\nincorporated by reference therein.<\/p>\n<p>1. <em>Representations and Warranties<\/em>. The Company represents and<br \/>\nwarrants to, and agrees with, you that:<\/p>\n<p>(a) (i) Each document, if any, filed or to be filed pursuant to the Exchange<br \/>\nAct and incorporated by reference in the Preliminary Memorandum, the Time of<br \/>\nSale Memorandum or the Final Memorandum complied or will comply when so filed in<br \/>\nall material respects with the Exchange Act and the applicable rules and<br \/>\nregulations of the Commission thereunder, (ii) the Time of Sale Memorandum does<br \/>\nnot, and at the time of each sale of the Securities in connection with the<br \/>\noffering when the Final Memorandum is not yet available to prospective<br \/>\npurchasers and at the Closing Date (as defined in Section 4), the Time of Sale<br \/>\nMemorandum, as then amended or supplemented by the Company, if applicable, will<br \/>\nnot, contain any untrue statement of a material fact or omit to state a material<br \/>\nfact necessary to make the statements therein, in the light of the circumstances<br \/>\nunder which they were made, not misleading, (iii) the Preliminary Memorandum<br \/>\ndoes not contain and the Final Memorandum, in the form used by the Initial<br \/>\nPurchasers to confirm sales and on the Closing Date (as defined in Section 4),<br \/>\nwill not contain any untrue statement of a material fact or omit to state a<br \/>\nmaterial fact necessary to make the statements therein, in the light of the<br \/>\ncircumstances under which they were made, not misleading, except that the<br \/>\nrepresentations and warranties set forth in this paragraph do not apply to<br \/>\nstatements or omissions in the Preliminary Memorandum, the Time of Sale<br \/>\nMemorandum or the Final Memorandum based upon information relating<\/p>\n<p align=\"center\">2<\/p>\n<p align=\"center\">\n<hr>\n<p>to any Initial Purchaser furnished to the Company in writing by such Initial<br \/>\nPurchaser through you expressly for use therein.<\/p>\n<\/p>\n<p>(b) Except for the Additional Written Offering Communications, if any,<br \/>\nidentified in Schedule III hereto, and electronic road shows, if any, furnished<br \/>\nto you before first use, the Company has not prepared, used or referred to, and<br \/>\nwill not, without your prior consent, prepare, use or refer to, any Additional<br \/>\nWritten Offering Communication.<\/p>\n<\/p>\n<p>(c) The Company has been duly incorporated, is validly existing as a<br \/>\ncorporation in good standing under the laws of the jurisdiction of its<br \/>\nincorporation, has the corporate power and authority to own its property and to<br \/>\nconduct its business as described in the Time of Sale Memorandum and is duly<br \/>\nqualified to transact business and is in good standing in each jurisdiction in<br \/>\nwhich the conduct of its business or its ownership or leasing of property<br \/>\nrequires such qualification, except to the extent that the failure to be so<br \/>\nqualified or be in good standing would not have a material adverse effect on the<br \/>\nCompany and its subsidiaries, taken as a whole.<\/p>\n<\/p>\n<p>(d) Each subsidiary of the Company listed on Schedule II hereto has been duly<br \/>\nincorporated, is validly existing as a corporation in good standing under the<br \/>\nlaws of the jurisdiction of its incorporation, has the corporate power and<br \/>\nauthority to own its property and to conduct its business as described in the<br \/>\nTime of Sale Memorandum and is duly qualified to transact business and is in<br \/>\ngood standing in each jurisdiction in which the conduct of its business or its<br \/>\nownership or leasing of property requires such qualification, except to the<br \/>\nextent that the failure to be so qualified or be in good standing would not have<br \/>\na material adverse effect on the Company and its subsidiaries, taken as a whole;<br \/>\nall of the issued shares of capital stock of each subsidiary of the Company<br \/>\nlisted on Schedule II hereto have been duly and validly authorized and issued,<br \/>\nare fully paid and non-assessable and are owned directly or indirectly by the<br \/>\nCompany, free and clear of all liens, encumbrances, equities or claims. The<br \/>\nsubsidiaries listed on Schedule II hereto are the only &#8220;significant<br \/>\nsubsidiaries&#8221; of the Company as that term is defined in Rule 1-02 of Regulation<br \/>\nS-X under the Exchange Act.<\/p>\n<\/p>\n<p>(e) This Agreement has been duly authorized, executed and delivered by the<br \/>\nCompany.<\/p>\n<\/p>\n<p>(f) The authorized capital stock of the Company conforms as to legal matters<br \/>\nto the description thereof contained in each of the Time of Sale Memorandum and<br \/>\nthe Final Memorandum.<\/p>\n<\/p>\n<p align=\"center\">3<\/p>\n<p align=\"center\">\n<hr>\n<p>(g) The shares of the Company153s common stock outstanding prior to the<br \/>\nissuance of the Securities have been duly authorized and are validly issued,<br \/>\nfully paid and non-assessable.<\/p>\n<\/p>\n<p>(h) The Securities have been duly authorized and, when executed and<br \/>\nauthenticated in accordance with the provisions of the Indenture and delivered<br \/>\nto and paid for by the Initial Purchasers in accordance with the terms of this<br \/>\nAgreement, will be valid and binding obligations of the Company, enforceable in<br \/>\naccordance with their terms, subject to applicable bankruptcy, insolvency and<br \/>\nsimilar laws affecting creditors153 rights generally and equitable principles of<br \/>\ngeneral applicability, and will be entitled to the benefits of the Indenture<br \/>\npursuant to which such Securities are to be issued. The issuance of such<br \/>\nSecurities will not be subject to any preemptive or similar rights.<\/p>\n<\/p>\n<p>(i) The Underlying Securities issuable upon conversion of the Securities have<br \/>\nbeen duly authorized and reserved and, when issued upon conversion of the<br \/>\nSecurities in accordance with the terms of the Securities, will be validly<br \/>\nissued, fully paid and non-assessable, and the issuance of the Underlying<br \/>\nSecurities will not be subject to any preemptive or similar rights.<\/p>\n<\/p>\n<p>(j) The Indenture has been duly authorized, and when executed and delivered<br \/>\nby the Company on the Closing Date, will be a valid and binding agreement of the<br \/>\nCompany, enforceable in accordance with its terms, subject to applicable<br \/>\nbankruptcy, insolvency and similar laws affecting creditors153 rights generally<br \/>\nand equitable principles of general applicability.<\/p>\n<\/p>\n<p>(k) The execution and delivery by the Company of, and the performance by the<br \/>\nCompany of its obligations under, this Agreement , the Indenture and the<br \/>\nSecurities will not contravene (i) in any material respect any provision of<br \/>\napplicable law, (ii) any provision of the certificate of incorporation or by<br \/>\nlaws of the Company, (iii) any agreement or other instrument binding upon the<br \/>\nCompany or any of its subsidiaries that is material to the Company and its<br \/>\nsubsidiaries, taken as a whole, or (iv) in any material respect any judgment,<br \/>\norder or decree of any governmental body, agency or court having jurisdiction<br \/>\nover the Company or any subsidiary. No consent, approval, authorization or order<br \/>\nof, or qualification with, any governmental body or agency is required for the<br \/>\nperformance by the Company of its obligations under this Agreement , the<br \/>\nIndenture or the Securities, except (1) such as may be required by the<br \/>\nsecurities or Blue Sky laws of the various states in connection with the offer<br \/>\nand sale of the Securities., (2) the notification to The NASDAQ<\/p>\n<\/p>\n<p align=\"center\">4<\/p>\n<p align=\"center\">\n<hr>\n<p>Stock Market, Inc. (&#8220;NASDAQ&#8221;) for the listing of the Underlying Securities or<br \/>\n(3) such as have already been obtained.<\/p>\n<\/p>\n<p>(l) There has not occurred any material adverse change, or any development<br \/>\nreasonably expected to have a prospective material adverse change, in the<br \/>\ncondition, financial or otherwise, or in the earnings, business or operations of<br \/>\nthe Company and its subsidiaries, taken as a whole, from that set forth in the<br \/>\nTime of Sale Memorandum provided to prospective purchasers of the Securities.\n<\/p>\n<\/p>\n<p>(m) The financial statements and the related notes thereto of the Company and<br \/>\nits consolidated subsidiaries included or incorporated by reference in the Time<br \/>\nof Sale Memorandum present fairly, in all material respects, the financial<br \/>\nposition of the Company and its consolidated subsidiaries as of the dates<br \/>\nindicated and the results of their operations and the changes in their cash<br \/>\nflows for the periods specified; such financial statements have been prepared in<br \/>\nconformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) applied<br \/>\non a consistent basis throughout the periods covered thereby.<\/p>\n<\/p>\n<p>(n) Other than proceedings accurately described in all material respects in<br \/>\nthe Time of Sale Memorandum, there are no legal or governmental proceedings<br \/>\npending or, to the Company153s knowledge, threatened to which the Company or any<br \/>\nof its subsidiaries is a party or to which any of the properties of the Company<br \/>\nor any of its subsidiaries is subject that would have a material adverse effect<br \/>\non the Company and its subsidiaries, taken as a whole, or on the power or<br \/>\nability of the Company to perform its obligations under this Agreement, the<br \/>\nIndenture or the Securities or to consummate the transactions contemplated by<br \/>\nthe Time of Sale Memorandum.<\/p>\n<\/p>\n<p>(o) The Company and its subsidiaries (i) are in compliance with any and all<br \/>\napplicable foreign, federal, state and local laws and regulations relating to<br \/>\nthe protection of human health and safety, the environment or hazardous or toxic<br \/>\nsubstances or wastes, pollutants or contaminants (&#8220;<strong>Environmental<br \/>\nLaws<\/strong>&#8220;), (ii) have received all permits, licenses or other approvals<br \/>\nrequired of them under applicable Environmental Laws to conduct their respective<br \/>\nbusinesses as described in the Time of Sale Memorandum and (iii) are in<br \/>\ncompliance with all terms and conditions of any such permit, license or<br \/>\napproval, except where such noncompliance with Environmental Laws, failure to<br \/>\nreceive required permits, licenses or other approvals or failure to comply with<br \/>\nthe terms and conditions of such permits, licenses or approvals would not,<br \/>\nsingly or<\/p>\n<\/p>\n<p align=\"center\">5<\/p>\n<p align=\"center\">\n<hr>\n<p>in the aggregate, have a material adverse effect, or prospective material<br \/>\nadverse effect, on the Company and its subsidiaries, taken as a whole.<\/p>\n<\/p>\n<p>(p) There are no costs or liabilities associated with Environmental Laws<br \/>\n(including, without limitation, any capital or operating expenditures required<br \/>\nfor clean-up, closure of properties or compliance with Environmental Laws or any<br \/>\npermit, license or approval required of the Company or its subsidiaries under<br \/>\napplicable Environmental Laws and any potential liabilities to third parties)<br \/>\nwhich would, singly or in the aggregate, have a material adverse effect on the<br \/>\nCompany and its subsidiaries, taken as a whole.<\/p>\n<\/p>\n<p>(q) The Company is not, and after giving effect to the offering and sale of<br \/>\nthe Securities and the application of the proceeds thereof as described in the<br \/>\nFinal Memorandum will not be, required to register as an &#8220;investment company&#8221; as<br \/>\nsuch term is defined in the Investment Company Act of 1940, as amended (the<br \/>\n&#8220;<strong>Investment Company Act<\/strong>&#8220;).<\/p>\n<\/p>\n<p>(r) Neither the Company nor any affiliate (as defined in Rule 501(b) of<br \/>\nRegulation D under the Securities Act, an &#8220;<strong>Affiliate<\/strong>&#8220;) of the<br \/>\nCompany has directly, or through any agent, (i) sold, offered for sale,<br \/>\nsolicited offers to buy or otherwise negotiated in respect of, any security (as<br \/>\ndefined in the Securities Act) which is or will be integrated with the sale of<br \/>\nthe Securities in a manner that would require the registration under the<br \/>\nSecurities Act of the Securities or (ii) offered, solicited offers to buy or<br \/>\nsold the Securities by any form of general solicitation or general advertising<br \/>\n(as those terms are used in Regulation D under the Securities Act) or in any<br \/>\nmanner involving a public offering within the meaning of Section 4(2) of the<br \/>\nSecurities Act, except no representation, warranty or agreement is made by the<br \/>\nCompany in this paragraph with respect to the Initial Purchasers.<\/p>\n<\/p>\n<p>(s) Assuming the representations of the Initial Purchasers set forth in<br \/>\nSection 7 are true and correct, it is not necessary in connection with the<br \/>\noffer, sale and delivery of the Securities to the Initial Purchasers in the<br \/>\nmanner contemplated by this Agreement to register the Securities under the<br \/>\nSecurities Act or to qualify the Indenture under the Trust Indenture Act of<br \/>\n1939, as amended.<\/p>\n<\/p>\n<p>(t) The Securities satisfy the requirements set forth in Rule 144A(d)(3)<br \/>\nunder the Securities Act.<\/p>\n<\/p>\n<p align=\"center\">6<\/p>\n<p align=\"center\">\n<hr>\n<p>(u) Neither the Company nor any of its subsidiaries, nor any director,<br \/>\nofficer or, to the Company153s knowledge, any employee, agent, affiliate or<br \/>\nrepresentative of the Company or of any of its subsidiaries or affiliates, has<br \/>\ntaken or will take any action in furtherance of an offer, payment, promise to<br \/>\npay, or authorization or approval of the payment or giving of money, property,<br \/>\ngifts or anything else of value, directly or indirectly, to any &#8220;government<br \/>\nofficial&#8221; (including any officer or employee of a government or government-owned<br \/>\nor controlled entity or of a public international organization, or any person<br \/>\nacting in an official capacity for or on behalf of any of the foregoing, or any<br \/>\npolitical party or party official or candidate for political office) to<br \/>\ninfluence official action or secure an improper advantage; and the Company and<br \/>\nits subsidiaries and, to the Company153s knowledge, its affiliates have conducted<br \/>\ntheir respective businesses as described in the Time of Sale Memorandum in<br \/>\ncompliance with applicable anti-corruption laws and have instituted and maintain<br \/>\nand will continue to maintain policies and procedures designed to promote and<br \/>\nachieve compliance with such laws and with the representation and warranty<br \/>\ncontained herein.<\/p>\n<\/p>\n<p>(v) The operations of the Company and its subsidiaries are and have been<br \/>\nconducted at all times in material compliance with all applicable financial<br \/>\nrecordkeeping and reporting requirements, including those of the Bank Secrecy<br \/>\nAct, as amended by Title III of the Uniting and Strengthening America by<br \/>\nProviding Appropriate Tools Required to Intercept and Obstruct Terrorism Act of<br \/>\n2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of<br \/>\njurisdictions where the Company and its subsidiaries conduct their respective<br \/>\nbusinesses as described in the Time of Sale Memorandum, the rules and<br \/>\nregulations thereunder and any related or similar rules, regulations or<br \/>\nguidelines, issued, administered or enforced by any governmental agency<br \/>\n(collectively, the &#8220;<strong>Anti-Money Laundering Laws<\/strong>&#8220;), and no<br \/>\naction, suit or proceeding by or before any court or governmental agency,<br \/>\nauthority or body or any arbitrator involving the Company or any of its<br \/>\nsubsidiaries with respect to the Anti-Money Laundering Laws is pending or, to<br \/>\nthe best knowledge of the Company, threatened.<\/p>\n<\/p>\n<p>(w) (i) The Company represents that neither the Company nor any of its<br \/>\nsubsidiaries, nor any director, officer or to the Company153s knowledge, any<br \/>\nemployee, agent, affiliate or representative of the Company or any of its<br \/>\nsubsidiaries, is an individual or entity (&#8220;<strong>Person<\/strong>&#8220;) that is, or<br \/>\nis owned or controlled by a Person that is:<\/p>\n<\/p>\n<p>(A) the subject of any sanctions administered or enforced by the U.S.<br \/>\nDepartment of Treasury153s Office of Foreign Assets Control<br \/>\n(&#8220;<strong>OFAC<\/strong>&#8220;) (the, &#8220;<strong>Sanctions<\/strong>&#8220;), nor<\/p>\n<\/p>\n<p align=\"center\">7<\/p>\n<p align=\"center\">\n<hr>\n<p>(B) located, organized or resident in a country or territory that is the<br \/>\nsubject of Sanctions (including, without limitation, Burma\/Myanmar, Cuba, Iran,<br \/>\nNorth Korea, Sudan and Syria).<\/p>\n<\/p>\n<p>(ii) The Company represents and covenants that it will not, directly or<br \/>\nindirectly, use the proceeds of the offering, or lend, contribute or otherwise<br \/>\nmake available such proceeds to any subsidiary, joint venture partner or other<br \/>\nPerson:<\/p>\n<\/p>\n<p>(A) to fund or facilitate any activities or business of or with any Person or<br \/>\nin any country or territory that, at the time of such funding or facilitation,<br \/>\nis the subject of Sanctions; or<\/p>\n<\/p>\n<p>(B) in any other manner that will result in a violation of Sanctions by any<br \/>\nPerson (including any Person participating in the offering, whether as<br \/>\nunderwriter, advisor, investor or otherwise).<\/p>\n<\/p>\n<p>(iii) The Company represents and covenants that for the past 5 years, it and<br \/>\nits subsidiaries have not knowingly engaged in, are not now knowingly engaged<br \/>\nin, and will not engage in, any dealings or transactions with any Person, or in<br \/>\nany country or territory, that at the time of the dealing or transaction is or<br \/>\nwas the subject of Sanctions.<\/p>\n<\/p>\n<p>(x) The Company and each of its subsidiaries have filed all federal, state,<br \/>\nlocal and foreign tax returns required to be filed through the date of this<br \/>\nAgreement or have requested extensions thereof (except where the failure to file<br \/>\nwould not, individually or in the aggregate, have a material adverse effect on<br \/>\nthe Company and its subsidiaries, taken as a whole) and have paid all taxes<br \/>\nrequired to be paid thereon (except for cases in which the failure to file or<br \/>\npay would not have a material adverse effect on the Company and its<br \/>\nsubsidiaries, taken as a whole, or, except as currently being contested in good<br \/>\nfaith and for which reserves required by GAAP have been created in the financial<br \/>\nstatements of the Company), and no tax deficiency has been determined adversely<br \/>\nto the Company or any of its subsidiaries which has had (nor does the Company<br \/>\nnor any of its subsidiaries have any notice or knowledge of any tax deficiency<br \/>\nwhich could reasonably be expected to be determined adversely to the Company or<br \/>\nits subsidiaries) and which could reasonably be expected to have) a material<br \/>\nadverse effect on the Company and its subsidiaries, taken as a whole.<\/p>\n<\/p>\n<p>(y) The Company and its subsidiaries have good and marketable title in fee<br \/>\nsimple to all real property and good and marketable title to all personal<br \/>\nproperty owned by them which is material to the business of the Company and its<br \/>\nsubsidiaries as described in the Time of<\/p>\n<\/p>\n<p align=\"center\">8<\/p>\n<p align=\"center\">\n<hr>\n<p>Sale Memorandum, in each case free and clear of all liens, encumbrances and<br \/>\ndefects except such as are described in the Time of Sale Memorandum or such as<br \/>\ndo not materially affect the value of such property and do not interfere with<br \/>\nthe use made and proposed to be made of such property by the Company and its<br \/>\nsubsidiaries; and any real property and buildings held under lease by the<br \/>\nCompany and its subsidiaries are held by them under valid, subsisting and<br \/>\nenforceable leases with such exceptions as are not material and do not<br \/>\nmaterially interfere with the use made and proposed to be made of such property<br \/>\nand buildings by the Company and its subsidiaries, in each case except as<br \/>\ndescribed in the Time of Sale Memorandum.<\/p>\n<\/p>\n<p>(z) Except as disclosed in the Time of Sale Memorandum, the Company and its<br \/>\nsubsidiaries own or possess, or can acquire on reasonable terms, adequate rights<br \/>\nto trademarks, service marks, trade names, copyrights, know-how (including trade<br \/>\nsecrets and confidential information, systems or procedures) and issued material<br \/>\npatents (or pending material patent applications of which the Company or its<br \/>\nsubsidiaries has knowledge) (collectively, &#8220;Intellectual Property Rights&#8221;)<br \/>\nnecessary to conduct the business now operated by the Company and its<br \/>\nsubsidiaries, and except as disclosed in the Time of Sale Memorandum, neither<br \/>\nthe Company nor any of its subsidiaries has received any written notice of<br \/>\ninfringement of or conflict with asserted rights of others with respect to any<br \/>\nof the foregoing Intellectual Property Rights that, if determined adversely to<br \/>\nthe Company or any of its subsidiaries, singly or in the aggregate, would have a<br \/>\nmaterial adverse effect on the Company and its subsidiaries, taken as a whole.\n<\/p>\n<\/p>\n<p>(aa) No material labor dispute with the employees of the Company or any of<br \/>\nits subsidiaries exists, except as described in the Time of Sale Memorandum, or,<br \/>\nto the knowledge of the Company, is threatened; and the Company is not aware of<br \/>\nany existing or threatened labor disturbance by the employees of any of its<br \/>\nprincipal suppliers, manufacturers or contractors that could have a material<br \/>\nadverse effect on the Company and its subsidiaries, taken as a whole.<\/p>\n<\/p>\n<p>(bb) The Company and each of its subsidiaries are insured by insurers of<br \/>\nrecognized financial responsibility against such losses and risks and in such<br \/>\namounts as are prudent and customary in the businesses in which they are<br \/>\nengaged; neither the Company nor any of its subsidiaries has been refused any<br \/>\ninsurance coverage sought or applied for; and neither the Company nor any of its<br \/>\nsubsidiaries has any reason to believe that it will not be able to renew its<br \/>\nexisting insurance coverage as and when such coverage expires or to obtain<br \/>\nsimilar coverage from similar insurers as<\/p>\n<\/p>\n<p align=\"center\">9<\/p>\n<p align=\"center\">\n<hr>\n<p>may be necessary to continue its business at a cost that would not have a<br \/>\nmaterial adverse effect on the Company and its subsidiaries, taken as a whole,<br \/>\nexcept as described in the Time of Sale Memorandum.<\/p>\n<\/p>\n<p>(cc) The Company and its subsidiaries possess all certificates,<br \/>\nauthorizations and permits issued by the appropriate federal, state or foreign<br \/>\nregulatory authorities necessary to conduct their respective businesses as<br \/>\ndescribed in the Time of Sale Memorandum, except where the failure to possess<br \/>\nthe same would not, singly or in the aggregate, have a material adverse effect<br \/>\non the Company and its subsidiaries, taken as a whole, and neither the Company<br \/>\nnor any of its subsidiaries has received any notice of proceedings relating to<br \/>\nthe revocation or modification of any such certificate, authorization or permit<br \/>\nwhich, singly or in the aggregate, would have a material adverse effect on the<br \/>\nCompany and its subsidiaries, taken as a whole, except as described in the Time<br \/>\nof Sale Memorandum.<\/p>\n<\/p>\n<p>(dd) The Company and each of its subsidiaries maintain a system of &#8220;internal<br \/>\ncontrol over financial reporting&#8221; (as defined in Rule 13a-15 of the Exchange<br \/>\nAct)sufficient to provide reasonable assurance that (i) transactions are<br \/>\nexecuted in accordance with management153s general or specific authorizations;<br \/>\n(ii) transactions are recorded as necessary to permit preparation of financial<br \/>\nstatements in conformity with generally accepted accounting principles and to<br \/>\nmaintain asset accountability; (iii) access to assets is permitted only in<br \/>\naccordance with management153s general or specific authorization; and (iv) the<br \/>\nrecorded accountability for assets is compared with the existing assets at<br \/>\nreasonable intervals and appropriate action is taken with respect to any<br \/>\ndifferences. Except as described in the Time of Sale Memorandum, since the end<br \/>\nof the Company153s most recent audited fiscal year, there has been (i) no material<br \/>\nweakness in the Company153s internal control over financial reporting (whether or<br \/>\nnot remediated) and (ii) no change in the Company153s internal control over<br \/>\nfinancial reporting that has materially affected, or is reasonably likely to<br \/>\nmaterially affect, the Company153s internal control over financial reporting.<\/p>\n<\/p>\n<p>(ee) The Company has not taken and will not take, directly or indirectly, any<br \/>\naction designed to or that might be reasonably expected to (i) cause or result<br \/>\nin stabilization or manipulation of the price of the Securities or the<br \/>\nUnderlying Securities to facilitate the sale or resale of the Securities<br \/>\n(provided, however, that this paragraph shall not apply to any stabilization<br \/>\nactivities conducted by the Initial Purchasers, who shall remain solely<br \/>\nresponsible for such activities), or (ii) violate Regulation M under the<br \/>\nExchange Act.<\/p>\n<\/p>\n<p align=\"center\">10<\/p>\n<p align=\"center\">\n<hr>\n<p>It is acknowledged by the parties that the Company is contemplating<br \/>\nrepurchasing shares of its Common Stock as further described in the Time of Sale<br \/>\nMemorandum.<\/p>\n<\/p>\n<p>2. <em>Agreements to Sell and Purchase<\/em>. The Company hereby agrees to<br \/>\nsell to the several Initial Purchasers, and each Initial Purchaser, upon the<br \/>\nbasis of the representations and warranties herein contained, but subject to the<br \/>\nconditions hereinafter stated, agrees, severally and not jointly, to purchase<br \/>\nfrom the Company the respective principal amount of the Firm Securities set<br \/>\nforth in Schedule I hereto opposite its name at a purchase price of 97.25% of<br \/>\nthe principal amount thereof (the &#8220;<strong>Purchase Price<\/strong>&#8220;)plus accrued<br \/>\ninterest, if any, to the Closing Date.<\/p>\n<\/p>\n<p>On the basis of the representations and warranties contained in this<br \/>\nAgreement, and subject to its terms and conditions, the Company agrees to sell<br \/>\nto the Initial Purchasers the Additional Securities, and the Initial Purchasers<br \/>\nshall have the right to purchase, severally and not jointly, up to $45,000,000<br \/>\nprincipal amount of Additional Securities at the Purchase Price, plus accrued<br \/>\ninterest, if any, to the date of payment and delivery. You may exercise this<br \/>\nright on behalf of the Initial Purchasers in whole or from time to time in part<br \/>\nby giving written notice not later than 30 days after the date of this<br \/>\nAgreement. Any exercise notice shall specify the principal amount of Additional<br \/>\nSecurities to be purchased by the Initial Purchasers and the date on which such<br \/>\nAdditional Securities are to be purchased. Each purchase date must be at least<br \/>\none business day after the written notice is given and may not be earlier than<br \/>\nthe closing date for the Firm Securities nor later than ten business days after<br \/>\nthe date of such notice. Additional Securities may be purchased as provided in<br \/>\nSection 4 solely for the purpose of covering over-allotments made in connection<br \/>\nwith the offering of the Firm Securities. On each day, if any, that Additional<br \/>\nSecurities are to be purchased (an &#8220;<strong>Option Closing Date<\/strong>&#8220;), each<br \/>\nInitial Purchaser agrees, severally and not jointly, to purchase the principal<br \/>\namount of Additional Securities (subject to such adjustments to eliminate<br \/>\nfractional Securities as you may determine) that bears the same proportion to<br \/>\nthe total principal amount of Additional Securities to be purchased on such<br \/>\nOption Closing Date as the principal amount of Firm Securities set forth in<br \/>\nSchedule I opposite the name of such Initial Purchaser bears to the total<br \/>\nprincipal amount of Firm Securities.<\/p>\n<\/p>\n<p>3. <em>Terms of Offering<\/em>. You have advised the Company that the Initial<br \/>\nPurchasers will make an offering of the Securities purchased by the Initial<br \/>\nPurchasers hereunder as soon as practicable after this Agreement is entered into<br \/>\nas in your judgment is advisable.<\/p>\n<\/p>\n<p>4. <em>Payment and Delivery. <\/em>Payment for the Firm Securities shall be<br \/>\nmade to the Company in Federal or other funds immediately available in New<\/p>\n<\/p>\n<p align=\"center\">11<\/p>\n<p align=\"center\">\n<hr>\n<p>York City against delivery of such Firm Securities for the respective<br \/>\naccounts of the several Initial Purchasers at 10:00 a.m., New York City time, on<br \/>\nNovember 1, 2010, or at such other time on the same or such other date, in any<br \/>\nevent not later than November 2, 2010, as shall be designated in writing by you.<br \/>\nThe time and date of such payment are hereinafter referred to as the<br \/>\n&#8220;<strong>Closing Date<\/strong>.&#8221;<\/p>\n<\/p>\n<p>Payment for any Additional Securities shall be made to the Company in Federal<br \/>\nor other funds immediately available in New York City against delivery of such<br \/>\nAdditional Securities for the respective accounts of the several Initial<br \/>\nPurchasers at 10:00 a.m., New York City time, on the date specified in the<br \/>\ncorresponding notice described in Section 2 or at such other time on the same or<br \/>\non such other date, in any event not later than December 9, 2010, as shall be<br \/>\ndesignated in writing by you.<\/p>\n<\/p>\n<p>The Securities shall be in definitive form or global form, as specified by<br \/>\nyou, and registered in such names and in such denominations as you shall request<br \/>\nin writing not later than one full business day prior to the Closing Date or the<br \/>\napplicable Option Closing Date, as the case may be. The Securities shall be<br \/>\ndelivered to you on the Closing Date or an Option Closing Date, as the case may<br \/>\nbe, for the respective accounts of the several Initial Purchasers, with any<br \/>\ntransfer taxes payable in connection with the transfer of the Securities to the<br \/>\nInitial Purchasers duly paid, against payment of the Purchase Price therefor<br \/>\nplus accrued interest, if any, to the date of payment and delivery.<\/p>\n<\/p>\n<p>5. <em>Conditions to the Initial Purchasers153 Obligations. <\/em>The several<br \/>\nobligations of the Initial Purchasers to purchase and pay for the Firm<br \/>\nSecurities on the Closing Date are subject to the following conditions:<\/p>\n<\/p>\n<p>(a) Subsequent to the execution and delivery of this Agreement and prior to<br \/>\nthe Closing Date:<\/p>\n<\/p>\n<p>(i) there shall not have occurred any downgrading, nor shall any notice have<br \/>\nbeen given of any intended or potential downgrading or of any review for a<br \/>\npossible change that does not indicate the direction of the possible change, in<br \/>\nthe rating accorded the Company or any of the securities of the Company or any<br \/>\nof its subsidiaries or in the rating outlook for the Company by any &#8220;nationally<br \/>\nrecognized statistical rating organization,&#8221; as such term is defined in Rule<br \/>\n15c3-1(c)(2)(vi)(F) of the Exchange Act; and<\/p>\n<\/p>\n<p>(ii) there shall not have occurred any change, or any development reasonably<br \/>\nexpected to have a prospective change, in the condition, financial or otherwise,<br \/>\nor in the earnings, business or operations of the Company and its subsidiaries,<br \/>\ntaken as a<\/p>\n<\/p>\n<p align=\"center\">12<\/p>\n<p align=\"center\">\n<hr>\n<p>whole, from that set forth in the Time of Sale Memorandum as of the date of<br \/>\nthis Agreement provided to the prospective purchasers of the Securities that, in<br \/>\nyour judgment, is material and adverse and that makes it, in your judgment,<br \/>\nimpracticable to market the Securities on the terms and in the manner<br \/>\ncontemplated in the Time of Sale Memorandum.<\/p>\n<\/p>\n<p>(b) The Representatives shall have received on the Closing Date a<br \/>\ncertificate, dated the Closing Date and signed by an executive officer of the<br \/>\nCompany, to the effect set forth in Section 5(a)(i) and to the effect that the<br \/>\nrepresentations and warranties of the Company contained in this Agreement are<br \/>\ntrue and correct as of the Closing Date and that the Company has complied with<br \/>\nall of the agreements and satisfied all of the conditions on its part to be<br \/>\nperformed or satisfied hereunder on or before the Closing Date.<\/p>\n<\/p>\n<p>The officer signing and delivering such certificate may rely upon the best of<br \/>\nhis or her knowledge as to proceedings threatened.<\/p>\n<\/p>\n<p>(c) The Representatives shall have received on the Closing Date an opinion of<br \/>\nHoward Rice Nemerovski Canady Falk &amp; Rabkin, A Professional Corporation,<br \/>\noutside special counsel for the Company, dated the Closing Date, to the effect<br \/>\nset forth in Exhibit A. Such opinion shall be rendered to the Representatives at<br \/>\nthe request of the Company and shall so state therein.<\/p>\n<\/p>\n<p>(d) The Representatives shall have received on the Closing Date an opinion of<br \/>\nKevin Crudden, Vice President and General Counsel of the Company, dated the<br \/>\nClosing Date, to the effect set forth in Exhibit B. Such opinion shall be<br \/>\nrendered to the Representatives at the request of the Company and shall so state<br \/>\ntherein.<\/p>\n<\/p>\n<p>(e) The Representatives shall have received on the Closing Date an opinion of<br \/>\nDavis Polk &amp; Wardwell LLP, counsel for the Initial Purchasers, dated the<br \/>\nClosing Date, to the effect set forth in Exhibit C.<\/p>\n<\/p>\n<p>(f) The Representatives shall have received on each of the date hereof and<br \/>\nthe Closing Date a letter, dated the date hereof or the Closing Date, as the<br \/>\ncase may be, in form and substance satisfactory to the Representatives, from<br \/>\nErnst &amp; Young LLP, independent public accountants, containing statements and<br \/>\ninformation of the type ordinarily included in accountants153 &#8220;comfort letters&#8221; to<br \/>\nunderwriters with respect to the financial statements and certain financial<br \/>\ninformation contained in or incorporated by reference into the Time of Sale<br \/>\nMemorandum and the<\/p>\n<\/p>\n<p align=\"center\">13<\/p>\n<p align=\"center\">\n<hr>\n<p>Final Memorandum; <em>provided <\/em>that the letter delivered on the Closing<br \/>\nDate shall use a &#8220;cut-off date&#8221; not earlier than the date hereof.<\/p>\n<\/p>\n<p>(g) The &#8220;lock-up&#8221; agreements, each substantially in the form of Exhibit D<br \/>\nhereto, between you and the officers and directors of the Company relating to<br \/>\nsales and certain other dispositions of shares of common stock or certain other<br \/>\nsecurities, delivered to you on or before the date hereof, shall be in full<br \/>\nforce and effect on the Closing Date.<\/p>\n<\/p>\n<p>(h) At the time of execution of this Agreement, the Representatives shall<br \/>\nhave received a certificate of Thomas M. Donnelly, Chief Financial Officer of<br \/>\nthe Company in form and substance satisfactory to the Representatives.<\/p>\n<\/p>\n<p>(i) At the Closing Time, the Representatives shall have received a<br \/>\ncertificate of Thomas M. Donnelly, Chief Financial Officer of the Company in<br \/>\nform and substance satisfactory to the Representatives reaffirming the<br \/>\nstatements made in the letter furnished pursuant to subsection (h) of this<br \/>\nSection as of the date hereof.<\/p>\n<\/p>\n<p>(j) A notification for the listing of the Underlying Securities shall have<br \/>\nbeen submitted to NASDAQ.<\/p>\n<\/p>\n<p>The several obligations of the Initial Purchasers to purchase Additional<br \/>\nSecurities hereunder are subject to the delivery to you on the applicable Option<br \/>\nClosing Date of such documents as you may reasonably request with respect to the<br \/>\ngood standing of the Company, the due authorization, execution and<br \/>\nauthentication of the Additional Securities to be sold on such Option Closing<br \/>\nDate and other matters related to the execution and authentication of such<br \/>\nAdditional Securities.<\/p>\n<\/p>\n<p>6. <em>Covenants of the Company<\/em>. The Company covenants with each Initial<br \/>\nPurchaser as follows:<\/p>\n<\/p>\n<p>(a) To furnish to you in New York City, without charge, prior to 10:00 a.m.<br \/>\nNew York City time on the second business day succeeding the date of this<br \/>\nAgreement and during the period mentioned in Section 6(d) or (e), as many copies<br \/>\nof the Time of Sale Memorandum, the Final Memorandum, any documents incorporated<br \/>\nby reference therein and any supplements and amendments thereto as you may<br \/>\nreasonably request.<\/p>\n<\/p>\n<p>(b) Before amending or supplementing the Preliminary Memorandum, the Time of<br \/>\nSale Memorandum or the Final Memorandum, to furnish to you a copy of each such<br \/>\nproposed amendment or supplement<\/p>\n<\/p>\n<p align=\"center\">14<\/p>\n<p align=\"center\">\n<hr>\n<p>and not to use any such proposed amendment or supplement to which you<br \/>\nreasonably object.<\/p>\n<\/p>\n<p>(c) To furnish to you a copy of each proposed Additional Written Offering<br \/>\nCommunication to be prepared by or on behalf of, used by, or referred to by the<br \/>\nCompany and not to use or refer to any proposed Additional Written Offering<br \/>\nCommunication to which you reasonably object.<\/p>\n<\/p>\n<p>(d) If the Time of Sale Memorandum is being used to solicit offers to buy the<br \/>\nSecurities at a time when the Final Memorandum is not yet available to<br \/>\nprospective purchasers and any event shall occur or condition exist as a result<br \/>\nof which it is necessary to amend or supplement the Time of Sale Memorandum in<br \/>\norder to make the statements therein, in the light of the circumstances, not<br \/>\nmisleading, or if, in the opinion of counsel for the Initial Purchasers, it is<br \/>\nnecessary to amend or supplement the Time of Sale Memorandum to comply with<br \/>\napplicable law, forthwith to prepare and furnish, at its own expense, to the<br \/>\nInitial Purchasers and to any dealer upon request, either amendments or<br \/>\nsupplements to the Time of Sale Memorandum so that the statements in the Time of<br \/>\nSale Memorandum as so amended or supplemented will not, in the light of the<br \/>\ncircumstances when delivered to a prospective purchaser, be misleading or so<br \/>\nthat the Time of Sale Memorandum, as amended or supplemented, will comply with<br \/>\napplicable law.<\/p>\n<\/p>\n<p>(e) If, during such period after the date hereof and prior to the date on<br \/>\nwhich all of the Securities shall have been sold by the Initial Purchasers, any<br \/>\nevent shall occur or condition exist as a result of which it is necessary to<br \/>\namend or supplement the Final Memorandum in order to make the statements<br \/>\ntherein, in the light of the circumstances when the Final Memorandum is<br \/>\ndelivered to a purchaser, not misleading, or if, in the opinion of counsel for<br \/>\nthe Initial Purchasers, it is necessary to amend or supplement the Final<br \/>\nMemorandum to comply with applicable law, forthwith to prepare and furnish to<br \/>\nthe Initial Purchasers, at the Company153s expense for a period of six months<br \/>\nfollowing the Closing Date and at the Initial Purchasers153 expense thereafter,<br \/>\neither amendments or supplements to the Final Memorandum so that the statements<br \/>\nin the Final Memorandum as so amended or supplemented will not, in the light of<br \/>\nthe circumstances when the Final Memorandum is delivered to a purchaser, be<br \/>\nmisleading or so that the Final Memorandum, as amended or supplemented, will<br \/>\ncomply with applicable law.<\/p>\n<\/p>\n<p>(f) To endeavor to qualify the Securities for offer and sale under the<br \/>\nsecurities or Blue Sky laws of such jurisdictions in the United<\/p>\n<\/p>\n<p align=\"center\">15<\/p>\n<p align=\"center\">\n<hr>\n<p>States and Canada as you shall reasonably request, provided that the Company<br \/>\nwill not be required to qualify as a foreign corporation or to file a general<br \/>\nconsent of service of process in any jurisdiction in which it is not otherwise<br \/>\nso qualified or subject.<\/p>\n<\/p>\n<p>(g) Whether or not the transactions contemplated in this Agreement are<br \/>\nconsummated or this Agreement is terminated, to pay or cause to be paid all<br \/>\nexpenses incident to the performance of the Company153s obligations under this<br \/>\nAgreement, including: (i) the fees, disbursements and expenses of the Company153s<br \/>\ncounsel and the Company153s accountants in connection with the issuance and sale<br \/>\nof the Securities and all other fees or expenses in connection with the<br \/>\npreparation of the Preliminary Memorandum, the Time of Sale Memorandum, the<br \/>\nFinal Memorandum, any Additional Written Offering Communication prepared by or<br \/>\non behalf of, used by, or referred to by the Company and any amendments and<br \/>\nsupplements to any of the foregoing, including all printing costs associated<br \/>\ntherewith, and the delivering of copies thereof to the Initial Purchasers, in<br \/>\nthe quantities herein above specified, (ii) all costs and expenses related to<br \/>\nthe transfer and delivery of the Securities to the Initial Purchasers, including<br \/>\nany transfer or other taxes payable thereon, (iii) the cost of printing or<br \/>\nproducing any Blue Sky or legal investment memorandum in connection with the<br \/>\noffer and sale of the Securities under state securities laws and all expenses in<br \/>\nconnection with the qualification of the Securities for offer and sale under<br \/>\nstate securities laws as provided in Section 6(f) hereof, including filing fees<br \/>\nand the reasonable fees and disbursements of counsel for the Initial Purchasers<br \/>\nin connection with such qualification and in connection with the Blue Sky or<br \/>\nlegal investment memorandum, (iv) any fees charged by rating agencies for the<br \/>\nrating of the Securities, (v) the fees and expenses, if any, incurred in<br \/>\nconnection with the admission of the Securities for trading on any appropriate<br \/>\nmarket system, (vi) the costs and charges of the Trustee and any transfer agent,<br \/>\nregistrar or depositary, (vii) the cost of the preparation, issuance and<br \/>\ndelivery of the Securities, (viii) the costs and expenses of the Company<br \/>\nrelating to investor presentations on any &#8220;road show&#8221; undertaken in connection<br \/>\nwith the marketing of the offering of the Securities, including, without<br \/>\nlimitation, expenses associated with the preparation or dissemination of any<br \/>\nelectronic road show, expenses associated with production of road show slides<br \/>\nand graphics, fees and expenses of any consultants engaged in connection with<br \/>\nthe road show presentations with the prior approval of the Company, travel and<br \/>\nlodging expenses of the representatives and officers of the Company and any such<br \/>\nconsultants, and the cost of any aircraft chartered in connection with the road<br \/>\nshow, (ix) the document production charges and expenses associated with printing<br \/>\nthis Agreement and (x) all other cost and expenses incident to the performance\n<\/p>\n<\/p>\n<p align=\"center\">16<\/p>\n<p align=\"center\">\n<hr>\n<p>of the obligations of the Company hereunder for which provision is not<br \/>\notherwise made in this Section. It is understood, however, that except as<br \/>\nprovided in this Section, Section 8, and the last paragraph of Section 10, the<br \/>\nInitial Purchasers will pay all of their costs and expenses, including fees and<br \/>\ndisbursements of their counsel, transfer taxes payable on resale of any of the<br \/>\nSecurities by them and any advertising expenses connected with any offers they<br \/>\nmay make.<\/p>\n<\/p>\n<p>(h) Neither the Company nor its Affiliate will sell, offer for sale or<br \/>\nsolicit offers to buy or otherwise negotiate in respect of any security (as<br \/>\ndefined in the Securities Act) which could be integrated with the sale of the<br \/>\nSecurities in a manner which would require the registration under the Securities<br \/>\nAct of the Securities.<\/p>\n<\/p>\n<p>(i) Not to solicit any offer to buy or offer or sell the Securities or the<br \/>\nUnderlying Securities by means of any form of general solicitation or general<br \/>\nadvertising (as those terms are used in Regulation D under the Securities Act)<br \/>\nor in any manner involving a public offering within the meaning of Section 4(2)<br \/>\nof the Securities Act.<\/p>\n<\/p>\n<p>(j) While any of the Securities or the Underlying Securities remain<br \/>\n&#8220;restricted securities&#8221; within the meaning of the Securities Act, to make<br \/>\navailable, upon request, to any seller of such Securities the information<br \/>\nspecified in Rule 144A(d)(4) under the Securities Act, unless the Company is<br \/>\nthen subject to Section 13 or 15(d) of the Exchange Act.<\/p>\n<\/p>\n<p>(k) During the period of two years after the Closing Date or any Option<br \/>\nClosing Date, if later, the Company will not be, nor will it become, an open-end<br \/>\ninvestment company, unit investment trust or face-amount certificate company<br \/>\nthat is or is required to be registered under Section 8 of the Investment<br \/>\nCompany Act.<\/p>\n<\/p>\n<p>(l) None of the Company, its Affiliates or any person acting on its or their<br \/>\nbehalf (other than the Initial Purchasers) will engage in any directed selling<br \/>\nefforts (as that term is defined in Regulation S) with respect to the<br \/>\nSecurities, and the Company and its Affiliates and each person acting on its or<br \/>\ntheir behalf (other than the Initial Purchasers) will comply with the offering<br \/>\nrestrictions requirement of Regulation S.<\/p>\n<\/p>\n<p>(m) During the period of six months after the Closing Date or any Option<br \/>\nClosing Date, if later, the Company will not, and will not permit any of its<br \/>\naffiliates (as defined in Rule 144 under the Securities Act) to resell any of<br \/>\nthe Securities or the Underlying Securities which constitute &#8220;restricted<br \/>\nsecurities&#8221; under Rule 144 that have been reacquired by any of them.<\/p>\n<\/p>\n<p align=\"center\">17<\/p>\n<p align=\"center\">\n<hr>\n<p>(n) Not to take any action prohibited by Regulation M under the Exchange Act<br \/>\nin connection with the distribution of the Securities contemplated hereby.<\/p>\n<\/p>\n<p>(o) The Company will reserve and keep available at all times, free of<br \/>\npre-emptive rights, shares of common stock for the purpose of enabling the<br \/>\nCompany to satisfy all obligations to issue the Underlying Securities upon<br \/>\nconversion of the Securities. The Company will use its reasonable efforts to<br \/>\ncause the Underlying Securities to be listed on NASDAQ.<\/p>\n<\/p>\n<p>The Company also agrees that, without the prior written consent of<br \/>\nRepresentatives on behalf of the Initial Purchasers, it will not, during the<br \/>\nperiod ending 90 days after the date of the Final Memorandum, (1) offer, pledge,<br \/>\nsell, contract to sell, sell any option or contract to purchase, purchase any<br \/>\noption or contract to sell, grant any option, right or warrant to purchase,<br \/>\nlend, or otherwise transfer or dispose of, directly or indirectly, any shares of<br \/>\ncommon stock or any securities convertible into or exercisable or exchangeable<br \/>\nfor common stock or (2) enter into any swap or other arrangement that transfers<br \/>\nto another, in whole or in part, any of the economic consequences of ownership<br \/>\nof the common stock, whether any such transaction described in clause (1) or (2)<br \/>\nabove is to be settled by delivery of common stock or such other securities, in<br \/>\ncash or otherwise. The foregoing sentence shall not apply to (a) the sale of the<br \/>\nSecurities under this Agreement, (b) grants of options, restricted stock, stock<br \/>\nappreciation rights, performance shares, restricted stock units or other rights<br \/>\nto purchase shares of common stock pursuant to the terms of an equity incentive<br \/>\nplan or stock purchase plan of the Company in effect on the date hereof and the<br \/>\nissuances by the Company of any shares of common stock pursuant to the exercise<br \/>\nof such options or rights, (c) the issuance by the Company of any shares of<br \/>\ncommon stock upon the exercise of an option or warrant or the conversion of a<br \/>\nsecurity outstanding on the date hereof, (d) the issuance by the Company of any<br \/>\nshares of common stock pursuant to its obligations with respect to the employer<br \/>\nstock funds included in the Company153s 401(k) Plan existing as of the date<br \/>\nhereof, or (e) the establishment of a trading plan pursuant to Rule 10b5-1 under<br \/>\nthe Exchange Act for the transfer of shares of common stock, provided that such<br \/>\nplan does not provide for the transfer of common stock during the 90-day<br \/>\nrestricted period and no public announcement or filing under the Exchange Act<br \/>\nregarding the establishment of such plan shall be required of or voluntarily<br \/>\nmade by or on behalf of the Company.<\/p>\n<\/p>\n<p>7. <em>Offering of Securities; Restrictions on Transfer<\/em>. (a) Each<br \/>\nInitial Purchaser, severally and not jointly, represents and warrants that such<br \/>\nInitial Purchaser is a qualified institutional buyer as defined in Rule 144A<br \/>\nunder the Securities Act (a &#8220;<strong>QIB<\/strong>&#8220;). Each Initial Purchaser,<br \/>\nseverally and not jointly, agrees<\/p>\n<\/p>\n<p align=\"center\">18<\/p>\n<p align=\"center\">\n<hr>\n<p>with the Company that (i) it will not solicit offers for, or offer or sell,<br \/>\nsuch Securities by any form of general solicitation or general advertising (as<br \/>\nthose terms are used in Regulation D under the Securities Act) or in any manner<br \/>\ninvolving a public offering within the meaning of Section 4(2) of the Securities<br \/>\nAct and (ii) it will solicit offers for such Securities only from, and will<br \/>\noffer such Securities only to, persons that it reasonably believes to be QIBs<br \/>\nthat in purchasing such Securities are deemed to have represented and agreed as<br \/>\nprovided in the Final Memorandum under the caption &#8220;Notice to Investors&#8221;.<\/p>\n<\/p>\n<p>(b) The Company agrees that the Initial Purchasers may provide copies of the<br \/>\nPreliminary Memorandum, the Time of Sale Memorandum, the Final Memorandum and<br \/>\nany other agreements or documents relating thereto, including without<br \/>\nlimitation, the Indenture to Xtract Research LLC (&#8220;Xtract&#8221;), following<br \/>\ncompletion of the offering, for inclusion in an online research service<br \/>\nsponsored by Xtract, access to which shall be restricted by Xtract to QIBs.<\/p>\n<\/p>\n<p>8. <em>Indemnity and Contribution<\/em>. (a) The Company agrees to indemnify<br \/>\nand hold harmless each Initial Purchaser, each person, if any, who controls any<br \/>\nInitial Purchaser within the meaning of either Section 15 of the Securities Act<br \/>\nor Section 20 of the Exchange Act, and each affiliate of any Initial Purchaser<br \/>\nwithin the meaning of Rule 405 under the Securities Act from and against any and<br \/>\nall losses, claims, damages and liabilities (including, without limitation, any<br \/>\nlegal or other expenses reasonably incurred in connection with defending or<br \/>\ninvestigating any such action or claim) caused by any untrue statement or<br \/>\nalleged untrue statement of a material fact contained in the Preliminary<br \/>\nMemorandum, the Time of Sale Memorandum, any Additional Written Offering<br \/>\nCommunication prepared by or on behalf of, used by, or referred to by the<br \/>\nCompany, or the Final Memorandum or any amendment or supplement thereto, or<br \/>\ncaused by any omission or alleged omission to state therein a material fact<br \/>\nnecessary to make the statements therein in the light of the circumstances under<br \/>\nwhich they were made not misleading, except insofar as such losses, claims,<br \/>\ndamages or liabilities are caused by any such untrue statement or omission or<br \/>\nalleged untrue statement or omission based upon information relating to any<br \/>\nInitial Purchaser furnished to the Company in writing by such Initial Purchaser<br \/>\nthrough you expressly for use therein.<\/p>\n<\/p>\n<p>(b) Each Initial Purchaser agrees, severally and not jointly, to indemnify<br \/>\nand hold harmless the Company, its directors, its officers and each person, if<br \/>\nany, who controls the Company within the meaning of either Section 15 of the<br \/>\nSecurities Act or Section 20 of the Exchange Act to the same extent as the<br \/>\nforegoing indemnity from the Company to such Initial Purchaser, but only with<br \/>\nreference to information relating to such Initial Purchaser furnished to the<br \/>\nCompany in writing by such Initial Purchaser through you expressly for use in<br \/>\nthe<\/p>\n<\/p>\n<p align=\"center\">19<\/p>\n<p align=\"center\">\n<hr>\n<p>Preliminary Memorandum, the Time of Sale Memorandum, any Additional Written<br \/>\nOffering Communication prepared by or on behalf of, used by or referred to by<br \/>\nthe Company, or the Final Memorandum or any amendment or supplement thereto.\n<\/p>\n<\/p>\n<p>(c) In case any proceeding (including any governmental investigation) shall<br \/>\nbe instituted involving any person in respect of which indemnity may be sought<br \/>\npursuant to Section 8(a) or 8(b), such person (the &#8220;<strong>indemnified<br \/>\nparty<\/strong>&#8220;) shall promptly notify the person against whom such indemnity<br \/>\nmay be sought (the &#8220;<strong>indemnifying party<\/strong>&#8220;) in writing and the<br \/>\nindemnifying party, upon request of the indemnified party, shall retain counsel<br \/>\nreasonably satisfactory to the indemnified party to represent the indemnified<br \/>\nparty and shall pay the reasonable fees and disbursements of such counsel<br \/>\nrelated to such proceeding. In any such proceeding, any indemnified party shall<br \/>\nhave the right to retain its own counsel, but the fees and expenses of such<br \/>\ncounsel shall be at the expense of such indemnified party unless (i) the<br \/>\nindemnifying party and the indemnified party shall have mutually agreed to the<br \/>\nretention of such counsel or (ii) the named parties to any such proceeding<br \/>\n(including any impleaded parties) include both the indemnifying party and the<br \/>\nindemnified party and representation of both parties by the same counsel would<br \/>\nbe inappropriate due to actual or potential conflicts of interests between them.<br \/>\nIt is understood that the indemnifying party shall not, in respect of the legal<br \/>\nexpenses of any indemnified party in connection with any proceeding or related<br \/>\nproceedings in the same jurisdiction, be liable for the fees and expenses of<br \/>\nmore than one separate firm (in addition to any local counsel) for all such<br \/>\nindemnified parties and that all such fees and expenses shall be reimbursed as<br \/>\nthey are incurred. Such firm shall be designated in writing by the<br \/>\nRepresentatives, in the case of parties indemnified pursuant to Section 8(a),<br \/>\nand by the Company, in the case of parties indemnified pursuant to Section 8(b).<br \/>\nThe indemnifying party shall not be liable for any settlement of any proceeding<br \/>\neffected without its written consent, but if settled with such consent or if<br \/>\nthere be a final judgment for the plaintiff, the indemnifying party agrees to<br \/>\nindemnify the indemnified party from and against any loss or liability by reason<br \/>\nof such settlement or judgment. Notwithstanding the foregoing sentence, if at<br \/>\nany time an indemnified party shall have requested an indemnifying party to<br \/>\nreimburse the indemnified party for fees and expenses of counsel as contemplated<br \/>\nby the second and third sentences of this paragraph, the indemnifying party<br \/>\nagrees that it shall be liable for any settlement of any proceeding effected<br \/>\nwithout its written consent if (i) such settlement is entered into more than 60<br \/>\ndays after receipt by such indemnifying party of the aforesaid request and (ii)<br \/>\nsuch indemnifying party shall not have reimbursed the indemnified party in<br \/>\naccordance with such request prior to the date of such settlement. No<br \/>\nindemnifying party shall, without the prior written consent of the indemnified<br \/>\nparty, effect any settlement of any pending or threatened proceeding in respect<br \/>\nof which any indemnified party is or could have been a party and<\/p>\n<\/p>\n<p align=\"center\">20<\/p>\n<p align=\"center\">\n<hr>\n<p>indemnity could have been sought hereunder by such indemnified party, unless<br \/>\nsuch settlement includes an unconditional release of such indemnified party from<br \/>\nall liability on claims that are the subject matter of such proceeding and does<br \/>\nnot include a statement as to or an admission of fault, culpability or a failure<br \/>\nto act by or on behalf of any indemnified party.<\/p>\n<\/p>\n<p>(d) To the extent the indemnification provided for in Section 8(a) or 8(b) is<br \/>\nunavailable to an indemnified party or insufficient in respect of any losses,<br \/>\nclaims, damages or liabilities referred to therein, then each indemnifying party<br \/>\nunder such paragraph, in lieu of indemnifying such indemnified party thereunder,<br \/>\nshall contribute to the amount paid or payable by such indemnified party as a<br \/>\nresult of such losses, claims, damages or liabilities (i) in such proportion as<br \/>\nis appropriate to reflect the relative benefits received by the Company on the<br \/>\none hand and the Initial Purchasers on the other hand from the offering of the<br \/>\nSecurities or (ii) if the allocation provided by clause 8(d)(i) above is not<br \/>\npermitted by applicable law, in such proportion as is appropriate to reflect not<br \/>\nonly the relative benefits referred to in clause 8(d)(i) above but also the<br \/>\nrelative fault of the Company on the one hand and of the Initial Purchasers on<br \/>\nthe other hand in connection with the statements or omissions that resulted in<br \/>\nsuch losses, claims, damages or liabilities, as well as any other relevant<br \/>\nequitable considerations. The relative benefits received by the Company on the<br \/>\none hand and the Initial Purchasers on the other hand in connection with the<br \/>\noffering of the Securities shall be deemed to be in the same respective<br \/>\nproportions as the net proceeds from the offering of the Securities (before<br \/>\ndeducting expenses) received by the Company and the total discounts and<br \/>\ncommissions received by the Initial Purchasers bear to the aggregate offering<br \/>\nprice of the Securities. The relative fault of the Company on the one hand and<br \/>\nof the Initial Purchasers on the other hand shall be determined by reference to,<br \/>\namong other things, whether the untrue or alleged untrue statement of a material<br \/>\nfact or the omission or alleged omission to state a material fact relates to<br \/>\ninformation supplied by the Company or by the Initial Purchasers and the<br \/>\nparties153 relative intent, knowledge, access to information and opportunity to<br \/>\ncorrect or prevent such statement or omission. The Initial Purchasers153<br \/>\nrespective obligations to contribute pursuant to this Section 8 are several in<br \/>\nproportion to the respective principal amount of Securities they have purchased<br \/>\nhereunder, and not joint.<\/p>\n<\/p>\n<p>(e) The Company and the Initial Purchasers agree that it would not be just or<br \/>\nequitable if contribution pursuant to this Section 8 were determined by <em>pro<br \/>\nrata <\/em>allocation (even if the Initial Purchasers were treated as one entity<br \/>\nfor such purpose) or by any other method of allocation that does not take<br \/>\naccount of the equitable considerations referred to in Section 8(d). The amount<br \/>\npaid or payable by an indemnified party as a result of the losses, claims,<br \/>\ndamages and liabilities referred to in Section 8(d) shall be deemed to include,<br \/>\nsubject to the limitations set forth above, any legal or other expenses<br \/>\nreasonably incurred by<\/p>\n<\/p>\n<p align=\"center\">21<\/p>\n<p align=\"center\">\n<hr>\n<p>such indemnified party in connection with investigating or defending any such<br \/>\naction or claim. Notwithstanding the provisions of this Section 8, no Initial<br \/>\nPurchaser shall be required to contribute any amount in excess of the purchase<br \/>\ndiscount or commissions received by such Initial Purchasers in connection with<br \/>\nthe Securities purchased by it and distributed to the public. No person guilty<br \/>\nof fraudulent misrepresentation (within the meaning of Section 11(f) of the<br \/>\nSecurities Act) shall be entitled to contribution from any person who was not<br \/>\nguilty of such fraudulent misrepresentation. The remedies provided for in this<br \/>\nSection 8 are not exclusive and shall not limit any rights or remedies which may<br \/>\notherwise be available to any indemnified party at law or in equity.<\/p>\n<\/p>\n<p>(f) The indemnity and contribution provisions contained in this Section 8 and<br \/>\nthe representations, warranties and other statements of the Company contained in<br \/>\nthis Agreement shall remain operative and in full force and effect regardless of<br \/>\n(i) any termination of this Agreement, (ii) any investigation made by or on<br \/>\nbehalf of any Initial Purchaser, any person controlling any Initial Purchaser or<br \/>\nany affiliate of any Initial Purchaser or by or on behalf of the Company, its<br \/>\nofficers or directors or any person controlling the Company and (iii) acceptance<br \/>\nof and payment for any of the Securities.<\/p>\n<\/p>\n<p>9. <em>Termination<\/em>. The Initial Purchasers may terminate this Agreement<br \/>\nby notice given by you to the Company, if after the execution and delivery of<br \/>\nthis Agreement and prior to the Closing Date (i) trading generally shall have<br \/>\nbeen suspended or materially limited on, or by, as the case may be, any of the<br \/>\nNew York Stock Exchange, the American Stock Exchange, the NASDAQ Global Market,<br \/>\nthe Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the<br \/>\nChicago Board of Trade, (ii) trading of any securities of the Company shall have<br \/>\nbeen suspended on any exchange or in any over-the-counter market, (iii) a<br \/>\nmaterial disruption in securities settlement, payment or clearance services in<br \/>\nthe United States shall have occurred, (iv) any moratorium on commercial banking<br \/>\nactivities shall have been declared by Federal or New York State authorities or<br \/>\n(v) there shall have occurred any outbreak or escalation of hostilities, or any<br \/>\nchange in financial markets or any calamity or crisis that, in your judgment, is<br \/>\nmaterial and adverse such that it, singly or together with any other event<br \/>\nspecified in this clause (v), makes it, in your judgment, impracticable or<br \/>\ninadvisable to proceed with the offer, sale or delivery of the Securities on the<br \/>\nterms and in the manner contemplated in the Time of Sale Memorandum or the Final<br \/>\nMemorandum.<\/p>\n<\/p>\n<p>10. <em>Effectiveness; Defaulting Initial Purchasers<\/em>. This Agreement<br \/>\nshall become effective upon the execution and delivery hereof by the parties<br \/>\nhereto.<\/p>\n<\/p>\n<p>If, on the Closing Date, or an Option Closing Date, as the case may be, any<br \/>\none or more of the Initial Purchasers shall fail or refuse to purchase<br \/>\nSecurities<\/p>\n<\/p>\n<p align=\"center\">22<\/p>\n<p align=\"center\">\n<hr>\n<p>that it or they have agreed to purchase hereunder on such date, and the<br \/>\naggregate principal amount of Securities which such defaulting Initial Purchaser<br \/>\nor Initial Purchasers agreed but failed or refused to purchase is not more than<br \/>\none-tenth of the aggregate principal amount of Securities to be purchased on<br \/>\nsuch date, the other Initial Purchasers shall be obligated severally in the<br \/>\nproportions that the principal amount of Firm Securities set forth opposite<br \/>\ntheir respective names in Schedule I bears to the aggregate principal amount of<br \/>\nFirm Securities set forth opposite the names of all such non-defaulting Initial<br \/>\nPurchasers, or in such other proportions as you may specify, to purchase the<br \/>\nSecurities which such defaulting Initial Purchaser or Initial Purchasers agreed<br \/>\nbut failed or refused to purchase on such date; <em>provided<\/em> that in no<br \/>\nevent shall the principal amount of Securities that any Initial Purchaser has<br \/>\nagreed to purchase pursuant to this Agreement be increased pursuant to this<br \/>\nSection 10 by an amount in excess of one-ninth of such principal amount of<br \/>\nSecurities without the written consent of such Initial Purchaser. If, on the<br \/>\nClosing Date any Initial Purchaser or Initial Purchasers shall fail or refuse to<br \/>\npurchase Firm Securities which it or they have agreed to purchase hereunder on<br \/>\nsuch date and the aggregate principal amount of Securities with respect to which<br \/>\nsuch default occurs is more than one-tenth of the aggregate principal amount of<br \/>\nFirm Securities to be purchased on such date, and arrangements satisfactory to<br \/>\nyou and the Company for the purchase of such Firm Securities are not made within<br \/>\n36 hours after such default, this Agreement shall terminate without liability on<br \/>\nthe part of any non-defaulting Initial Purchaser or of the Company. In any such<br \/>\ncase either you or the Company shall have the right to postpone the Closing<br \/>\nDate, but in no event for longer than seven days, in order that the required<br \/>\nchanges, if any, in the Time of Sale Memorandum, the Final Memorandum or in any<br \/>\nother documents or arrangements may be effected. If, on an Option Closing Date,<br \/>\nany Initial Purchaser or Initial Purchasers shall fail or refuse to purchase<br \/>\nAdditional Securities and the aggregate principal amount of Additional<br \/>\nSecurities with respect to which such default occurs is more than one-tenth of<br \/>\nthe aggregate principal amount of Additional Securities to be purchased on such<br \/>\nOption Closing Date, the non-defaulting Initial Purchasers shall have the option<br \/>\nto (a) terminate their obligation hereunder to purchase the Additional<br \/>\nSecurities to be sold on such Option Closing Date or (b) purchase not less than<br \/>\nthe principal amount of Additional Securities that such non-defaulting Initial<br \/>\nPurchasers would have been obligated to purchase in the absence of such default.<br \/>\nAny action taken under this paragraph shall not relieve any defaulting Initial<br \/>\nPurchaser from liability in respect of any default of such Initial Purchaser<br \/>\nunder this Agreement.<\/p>\n<\/p>\n<p>If this Agreement shall be terminated by the Initial Purchasers, or any of<br \/>\nthem, because of any failure or refusal on the part of the Company to comply<br \/>\nwith the terms or to fulfill any of the conditions of this Agreement, or if for<br \/>\nany reason the Company shall be unable to perform its obligations under this<br \/>\nAgreement, the Company will reimburse the Initial Purchasers or such Initial<br \/>\nPurchasers as have<\/p>\n<\/p>\n<p align=\"center\">23<\/p>\n<p align=\"center\">\n<hr>\n<p>so terminated this Agreement with respect to themselves, severally, for all<br \/>\nout-of-pocket expenses (including the fees and disbursements of their counsel)<br \/>\nreasonably incurred by such Initial Purchasers in connection with this Agreement<br \/>\nor the offering contemplated hereunder.<\/p>\n<\/p>\n<p>11. <em>Entire Agreement<\/em>. (a) This Agreement represents the entire<br \/>\nagreement between the Company and the Initial Purchasers with respect to the<br \/>\npreparation of the Preliminary Memorandum, the Time of Sale Memorandum, the<br \/>\nFinal Memorandum, the conduct of the offering, and the purchase and sale of the<br \/>\nSecurities.<\/p>\n<\/p>\n<p>(b) The Company acknowledges that in connection with the offering of the<br \/>\nSecurities: (i) the Initial Purchasers have acted at arms length, are not agents<br \/>\nof, and owe no fiduciary duties to, the Company or any other person, (ii) the<br \/>\nInitial Purchasers owe the Company only those duties and obligations set forth<br \/>\nin this Agreement and prior written agreements (to the extent not superseded by<br \/>\nthis Agreement) if any, and (iii) the Initial Purchasers may have interests that<br \/>\ndiffer from those of the Company. The Company waives to the full extent<br \/>\npermitted by applicable law any claims it may have against the Initial<br \/>\nPurchasers arising from an alleged breach of fiduciary duty in connection with<br \/>\nthe offering of the Securities.<\/p>\n<\/p>\n<p>12. <em>Counterparts. <\/em>This Agreement may be signed in two or more<br \/>\ncounterparts, each of which shall be an original, with the same effect as if the<br \/>\nsignatures thereto and hereto were upon the same instrument.<\/p>\n<\/p>\n<p>13. <em>Applicable Law. <\/em>This Agreement shall be governed by and<br \/>\nconstrued in accordance with the internal laws of the State of New York.<\/p>\n<\/p>\n<p>14. <em>Headings. <\/em>The headings of the sections of this Agreement have<br \/>\nbeen inserted for convenience of reference only and shall not be deemed a part<br \/>\nof this Agreement.<\/p>\n<\/p>\n<p>15. <em>Notices. <\/em>All communications hereunder shall be in writing and<br \/>\neffective only upon receipt and if to the Initial Purchasers shall be delivered,<br \/>\nmailed or sent to Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, 1<br \/>\nBryant Park, New York, New York 10036, Telecopy No.: 212-901-7881, Attention:<br \/>\nLegal and Morgan Stanley &amp; Co. Incorporated, 1585 Broadway, New York, New<br \/>\nYork 10036, and if to the Company shall be delivered, mailed or sent by<br \/>\nfacsimile to 9625 W. 76th Street, Suite 150, Eden Prairie, MN 55344, Attention:<br \/>\nChief Financial Officer, Fax: (952) 253-1234.<\/p>\n<\/p>\n<p align=\"center\">24<\/p>\n<p align=\"center\">\n<hr>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td colspan=\"3\">\n<p>Very truly yours,<\/p>\n<p>Digital River, Inc.<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\">\n<p>\/s\/ Thomas M. Donnelly<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td valign=\"top\">\n<p>Name:<\/p>\n<\/td>\n<td>\n<p>Thomas M. Donnelly<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td valign=\"top\">\n<p>Title:<\/p>\n<\/td>\n<td>\n<p>Chief Financial Officer<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">[Purchase Agreement]<\/p>\n<p align=\"center\">\n<hr>\n<p>size=2 width=&#8221;100%&#8221; noshade style=&#8217;color:#A0A0A0&#8242; align=center&gt;<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Accepted as of the date hereof<\/p>\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith<br \/>\nIncorporated<br \/>\nMorgan Stanley &amp; Co. Incorporated<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<td width=\"48%\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\">\n<p>Acting severally on behalf of themselves and the<br \/>\nseveral Initial Purchasers named in <br \/>\nSchedule I hereto.<\/p>\n<\/td>\n<td><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\">\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\">\n<p>\/s\/ Ric Spencer<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td valign=\"top\">\n<p>Name:<\/p>\n<\/td>\n<td>\n<p>Ric Spencer<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td valign=\"top\">\n<p>Title:<\/p>\n<\/td>\n<td>\n<p>MD<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\">\n<p>Morgan Stanley &amp; Co. Incorporated<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\">\n<p>\/s\/ Robert Brass<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td valign=\"top\">\n<p>Name:<\/p>\n<\/td>\n<td>\n<p>Robert Brass<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td valign=\"top\">\n<p>Title:<\/p>\n<\/td>\n<td>\n<p>Executive Director<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">[Purchase Agreement]<\/p>\n<hr>\n<p>size=2 width=&#8221;100%&#8221; noshade style=&#8217;color:#A0A0A0&#8242; align=center&gt;<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"right\"><strong>SCHEDULE I<\/strong><\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"88%\" valign=\"bottom\"><\/td>\n<td width=\"5%\" valign=\"bottom\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<td width=\"5%\" valign=\"bottom\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\"><\/td>\n<td colspan=\"2\" valign=\"bottom\">\n<p align=\"center\"><strong>Principal Amount of<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\"><\/td>\n<td colspan=\"2\" valign=\"bottom\">\n<p align=\"center\"><strong>Firm Securities to be<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>Initial Purchaser<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td colspan=\"2\" valign=\"bottom\">\n<p align=\"center\"><strong>Purchased<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>$<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p align=\"right\">150,000,000<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Morgan Stanley &amp; Co. Incorporated<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>$<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p align=\"right\">120,000,000<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Piper Jaffray &amp; Co.<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>$<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p align=\"right\">30,000,000<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Total:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>$<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p align=\"right\">300,000,000<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">I-1<\/p>\n<p align=\"center\">\n<hr>\n<p align=\"right\"><strong>SCHEDULE II<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>Significant Subsidiaries<\/strong><\/p>\n<p align=\"center\">\n<p>BlueHornet Networks, Inc.<\/p>\n<\/p>\n<p>Digital River GmbH<\/p>\n<\/p>\n<p>Digital River Technology Limited<\/p>\n<\/p>\n<p>Digital River Ireland Limited<\/p>\n<\/p>\n<p align=\"center\">II-1<\/p>\n<p align=\"center\">\n<hr>\n<p align=\"right\"><strong>SCHEDULE III<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>Time of Sale Memorandum<\/strong><\/p>\n<p align=\"center\">\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"1%\" valign=\"top\">\n<p>1.<\/p>\n<\/td>\n<td width=\"1%\" valign=\"top\"><\/td>\n<td valign=\"top\">\n<p>Preliminary Memorandum issued October 25, 2010<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td width=\"1%\" valign=\"top\">\n<p>2.<\/p>\n<\/td>\n<td width=\"1%\" valign=\"top\"><\/td>\n<td valign=\"top\">\n<p>Pricing Term Sheet dated October 26, 2010<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">III-1<\/p>\n<p align=\"center\">\n<hr>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"right\"><strong>EXHIBIT A<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>OPINION OF HOWARD RICE NEMEROVSKI CANADY FALK &amp;<br \/>\n<br \/>\nRABKIN, A PROFESSIONAL CORPORATION, OUTSIDE SPECIAL <br \/>\nCOUNSEL FOR THE COMPANY<\/strong><\/p>\n<p align=\"center\">\n<p align=\"center\">November ___, 2010<\/p>\n<p align=\"center\">\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nMorgan Stanley &amp; Co. Incorporated<\/p>\n<\/p>\n<p>As Representatives of the Initial Purchasers<\/p>\n<\/p>\n<p>c\/o Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nOne Bryant Park <br \/>\nNew York, NY 10036<\/p>\n<\/p>\n<p>c\/o Morgan Stanley &amp; Co. Incorporated <br \/>\n1585 Broadway <br \/>\nNew York, NY 10036<\/p>\n<\/p>\n<p><strong>Re: <\/strong>Digital River, Inc.<\/p>\n<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<\/p>\n<p>You have requested our opinion as special legal counsel to Digital River,<br \/>\nInc., a Delaware corporation (the &#8220;<strong><em>Company<\/em><\/strong>&#8220;), with<br \/>\nrespect to certain matters in connection with the offering of up to $300,000,000<br \/>\naggregate principal amount of 2.00% Convertible Senior Notes due 2030 to Merrill<br \/>\nLynch, Pierce, Fenner &amp; Smith Incorporated, Morgan Stanley &amp; Co.<br \/>\nIncorporated and Piper Jaffray &amp; Co., as Representatives of the several<br \/>\nInitial Purchasers (the &#8220;<strong><em>Initial Purchasers<\/em><\/strong>&#8220;),<br \/>\npursuant to that certain Purchase Agreement, dated October 26, 2010, between the<br \/>\nCompany and the Initial Purchasers (the &#8220;<strong><em>Agreement<\/em><\/strong>&#8220;).<br \/>\nExcept as otherwise specified, all capitalized terms used herein have the same<br \/>\nmeanings given to them in the Agreement. We are rendering this opinion at the<br \/>\nrequest of the Company pursuant to Section 5(c) of the Agreement.<\/p>\n<\/p>\n<p>In this connection, we have examined original or copies of the following<br \/>\ndocuments, each of which is dated the date hereof (unless otherwise specified):\n<\/p>\n<\/p>\n<p>1. The Time of Sale Memorandum for the Firm Notes (as defined below) dated<br \/>\nOctober 26, 2010 (the &#8220;<strong><em>Time of Sale Memorandum<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p align=\"center\">A-1<\/p>\n<p align=\"center\">\n<hr>\n<p>2. The Final Memorandum for the Firm Notes dated October [26], 2010 (the<br \/>\n&#8220;<strong><em>Final Memorandum<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>3. The Agreement;<\/p>\n<\/p>\n<p>4. The Indenture dated as of November 1, 2010 between the Company and Wells<br \/>\nFargo Bank, National Association, as trustee (the<br \/>\n&#8220;<strong><em>Trustee<\/em><\/strong>&#8220;) (the<br \/>\n&#8220;<strong><em>Indenture<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>5. The 2.00% Convertible Senior Notes dated November 1, 2010, issued by the<br \/>\nCompany in favor of the Initial Purchasers pursuant to the Agreement as of the<br \/>\ndate hereof (the <strong><em>&#8220;Firm Notes<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>6. The Company153s Amended and Restated Certificate of Incorporation, filed<br \/>\nwith the Secretary of State of Delaware on August 14, 1998, as amended by the<br \/>\nCertificates of Amendment, filed on September 20, 2000 and May 31, 2006 (the<br \/>\n&#8220;<strong><em>Charter<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>7. The Company153s Amended and Restated Bylaws as currently in effect (the<br \/>\n&#8220;<strong><em>Bylaws<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>8. Resolutions of the Board of Directors of the Company adopted on October<br \/>\n22, 2010 and the resolutions of the Negotiating Committee of the Board of<br \/>\nDirectors adopted on October 26, 2010 (the<br \/>\n<strong><em>&#8220;Resolutions&#8221;<\/em><\/strong>);<\/p>\n<\/p>\n<p>9. The Company153s Annual Report on Form 10-K filed with the Commission on<br \/>\nFebruary 23, 2010 as amended by Form 10-K\/A filed with the Commission on August<br \/>\n19, 2010 (collectively, the &#8220;<strong><em>Form 10-K<\/em><\/strong>&#8220;) pursuant to<br \/>\nthe Securities Exchange Act of 1934 (the &#8220;<strong><em>Exchange<br \/>\nAct<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>10. The Company153s Quarterly Reports on Form 10-Q (the &#8220;<strong><em>Form<br \/>\n10-Qs<\/em><\/strong>&#8220;) filed with the Commission on May 4, 2010 and August 5,<br \/>\n2010;<\/p>\n<\/p>\n<p>11. The Company153s Current Reports on Form 8-K and Form 8-K\/A (the<br \/>\n&#8220;<strong><em>Form 8-Ks<\/em><\/strong>&#8220;) filed with the Commission from January<br \/>\n28, 2010 to the date hereof;<\/p>\n<\/p>\n<p>12. The Company153s 2010 Proxy Statement filed with the Commission on March 30,<br \/>\n2010 (together with the Form 10-K, the Form 10-Qs and the Form 8-Ks, the<br \/>\n&#8220;<strong><em>Exchange Act Reports<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>13. The minute books of the Company provided to us by one or more officers of<br \/>\nthe Company;<\/p>\n<\/p>\n<p align=\"center\">A-2<\/p>\n<p align=\"center\">\n<hr>\n<p>14. The contracts of the Company listed on <u>Exhibit A<\/u> attached to this<br \/>\nletter (the &#8220;<strong><em>Company Contracts<\/em><\/strong>&#8220;); and<\/p>\n<\/p>\n<p>15. One or more certificates provided to us by one or more officers of the<br \/>\nCompany.<\/p>\n<\/p>\n<p>The agreements and documents described in Items 3 through 5 above are<br \/>\nreferred to herein as the &#8220;<strong><em>Transaction Agreements<\/em><\/strong>.&#8221;\n<\/p>\n<\/p>\n<p>In rendering the opinions set forth below, we have assumed the legal capacity<br \/>\nof individuals, that the signatures on all documents not executed in our<br \/>\npresence are genuine, that all documents submitted to us as originals are<br \/>\nauthentic, that all documents submitted to us as reproduced or certified copies<br \/>\nconform to the original documents, that all corporate records of the Company<br \/>\nprovided to us for review are accurate and complete, and that any reviews and<br \/>\nsearches of public records obtained by us are accurate and complete. We have<br \/>\nfurther assumed that each of the parties to the Transaction Agreements (other<br \/>\nthan the Company) and each holder of the Firm Notes is duly qualified to engage<br \/>\nin the transactions contemplated by the Transaction Agreements and to hold the<br \/>\nFirm Notes; that the Transaction Agreements have been duly authorized, executed,<br \/>\nand delivered by, and constitute the valid and binding obligation of, the<br \/>\nInitial Purchasers and, in the case of the Indenture only, the Trustee, and is<br \/>\nenforceable against the Initial Purchasers and, in the case of the Indenture<br \/>\nonly, the Trustee, in accordance with their respective terms; that the parties<br \/>\nto the Transaction Agreements (other than the Company) and the holders of the<br \/>\nFirm Notes have the requisite power and authority to perform their respective<br \/>\nobligations under the Transaction Agreements; and that there are no documents,<br \/>\nagreements or understandings among or between any parties to the Transaction<br \/>\nAgreements and the holders of the Firm Notes or other agreements that would<br \/>\nmodify the respective rights and obligations of such parties as set forth in the<br \/>\nTransaction Agreements or that otherwise would have an effect on the opinions<br \/>\nrendered below.<\/p>\n<\/p>\n<p>As to matters of fact material to our opinions, we have relied solely upon<br \/>\nour review of the documents referred to in the second paragraph of this letter.<br \/>\nWe have assumed that the recitals of fact and the representations and warranties<br \/>\nof all parties as to factual matters set forth in the documents referred to<br \/>\nabove are true, complete and correct on the date hereof. We have not<br \/>\nindependently verified any factual matters or the validity of any assumptions<br \/>\nmade by us in this letter.<\/p>\n<\/p>\n<p>For purposes of rendering the opinions set forth in enumerated paragraphs 1<br \/>\nthrough 11 below, we have considered only Applicable Laws (as defined herein).<br \/>\n&#8220;<strong><em>Applicable Laws<\/em><\/strong>&#8221; means those laws, statutes, rules<br \/>\nand<\/p>\n<\/p>\n<p align=\"center\">A-3<\/p>\n<p align=\"center\">\n<hr>\n<p>regulations of the State of California, the Delaware General Corporation Law<br \/>\n(the &#8220;<strong><em>DGCL<\/em><\/strong>&#8220;) and the federal laws of the United States<br \/>\nof America as presently in effect that, in our experience, are normally<br \/>\napplicable to a securities offering of the type contemplated by the Transaction<br \/>\nAgreements, other than the Excluded Laws (as defined herein).<br \/>\n&#8220;<strong><em>Excluded Laws<\/em><\/strong>&#8221; means any laws, statutes, rules or<br \/>\nregulations: (a) of any county, locality or municipality, (b) pertaining to<br \/>\ntaxes (except to the limited extent set forth in paragraph 9); securities<br \/>\n(except to the limited extent set forth in paragraphs 6 and 7 below); labor,<br \/>\nemployee or management relations; money laundering; privacy; environment; health<br \/>\nand safety; trade regulation; franchising; antitrust or unfair competition, (c)<br \/>\nrelating to choice of law or conflicts of law (except to the limited extent set<br \/>\nforth in paragraph 11 below), and\/or (d) to which the transactions are or may be<br \/>\nsubject because of the legal or regulatory status of any person other than the<br \/>\nCompany or because of any facts pertaining to any such person. We note that if<br \/>\nthe Transaction Agreements are not valid, binding and enforceable under the laws<br \/>\nof New York, the Transaction Agreements may not be enforced by a California<br \/>\ncourt under applicable conflicts-of-law principles. We call your attention to<br \/>\nthe fact that Excluded Laws may apply to the Transaction Agreements and express<br \/>\nno opinion with respect to the effect of Excluded Laws on the opinions set forth<br \/>\nherein.<\/p>\n<\/p>\n<p>Although the Transaction Agreements contain choice-of-law provisions<br \/>\nspecifying that they are governed by the laws of the State of New York, you are<br \/>\naware that we are not admitted to practice in the State of New York and you have<br \/>\nasked us to provide you with the opinions set forth below on the assumption (and<br \/>\nwe have therefore assumed) that the Transaction Agreements are governed by the<br \/>\nsubstantive laws of the State of California (without regard to conflicts-of-law<br \/>\nand choice-of-law principles), even though such assumption is or may be contrary<br \/>\nto fact. In addition, and without limiting the generality of the foregoing, you<br \/>\nhave asked us to provide you with this opinion on the assumption that each of<br \/>\nthe Company Contracts is governed by the substantive laws of the State of<br \/>\nCalifornia (without regard to conflicts-of-law and choice-of-law principles),<br \/>\neven though such assumption is or may be contrary to fact.<\/p>\n<\/p>\n<p>Whenever a statement or opinion herein is qualified by the phrase &#8220;known to<br \/>\nus,&#8221; &#8220;to our knowledge,&#8221; or any similar phrase, we intend to indicate that no<br \/>\ninformation that gives current actual knowledge of the inaccuracy of such<br \/>\nstatement or opinion has come to the attention of those attorneys in this law<br \/>\nfirm who have rendered legal services in connection with the representation of<br \/>\nthe Company. We have not undertaken or conducted any independent investigation<br \/>\nto determine the accuracy of statements or opinions herein qualified as<br \/>\ndescribed in the preceding sentence, and any limited inquiry undertaken by us<br \/>\nduring the preparation of this opinion letter should not be regarded as such an<br \/>\ninvestigation; no inference as to our knowledge of any matters bearing on the<br \/>\naccuracy of any<\/p>\n<\/p>\n<p align=\"center\">A-4<\/p>\n<p align=\"center\">\n<hr>\n<p>such statement or opinion should be drawn from the fact of our representation<br \/>\nof the Company.<\/p>\n<\/p>\n<p>The opinions set forth below are subject to the following:<\/p>\n<\/p>\n<p>(i) In rendering our opinion in clause (c) of paragraph 2 of this letter, we<br \/>\nexpress no opinion as to financial covenants or similar provisions in the<br \/>\nCompany Contracts requiring financial calculations or determinations.<\/p>\n<\/p>\n<p>(ii) In rendering our opinion in paragraph 6 of this letter, we have assumed,<br \/>\nwithout investigation, that the Initial Purchasers153 representations in the<br \/>\nAgreement are correct.<\/p>\n<\/p>\n<p>(iii) In rendering our opinion in paragraphs 5, 6 and 7 of this letter, we<br \/>\nhave assumed that as of the date and time of the issuance of any shares of the<br \/>\nCompany153s Common Stock resulting from a conversion of the Firm Notes pursuant to<br \/>\nand as provided in the Firm Notes: (A) all of the Firm Notes being surrendered<br \/>\nupon such conversion will at that time be free and clear of any liens and<br \/>\nencumbrances; (B) all of the terms and conditions for such conversion set forth<br \/>\nin the Firm Notes will have been fully satisfied, waived or discharged; and (C)<br \/>\napplicable law, including its interpretation, will remain unchanged from the law<br \/>\nin effect as of the date of this letter. Subsequent dispositions, pledges or<br \/>\nother transfers of the Firm Notes without registration or qualification under<br \/>\nthe Securities Act may affect the availability of the exemptions from<br \/>\nregistration referred to in paragraph 6 of this letter. We have further assumed,<br \/>\nin rendering our opinion in paragraphs 5 and 7 of this letter, that sufficient<br \/>\nshares of the Company153s Common Stock issuable upon conversion of the Firm Notes<br \/>\npursuant to and as provided in the Firm Notes will remain duly authorized and<br \/>\navailable for issuance to satisfy the Company153s obligations upon such<br \/>\nconversion.<\/p>\n<\/p>\n<p>(iv) In rendering our opinion in paragraph 8 of this letter, we have relied<br \/>\non a certificate executed by one or more officers of the Company as to nature of<br \/>\nthe Company153s business and investments as of the date hereof, and we have<br \/>\nassumed that none of the net proceeds of the offering will be invested in<br \/>\nsecurities other than &#8220;Government securities&#8221; as such term is defined in the<br \/>\nInvestment Company Act of 1940, as amended (the &#8220;<strong><em>1940<br \/>\nAct<\/em><\/strong>&#8220;).<\/p>\n<\/p>\n<p>(v) In rendering our opinion in paragraph 11 of this letter, we have, with<br \/>\nyour permission, assumed the following factual matters: (a) one or more of the<br \/>\nInitial Purchasers has its headquarters office or a principal place of business<br \/>\nin the State of New York; (b) the Trustee has a substantial corporate presence<br \/>\nin the State of New York; (c) one or more senior executives of the Trustee153s<br \/>\ncorporate trust business are located in the State of New York; (d) the Trustee<br \/>\nhas negotiated the provisions of the Indenture with the material assistance of<br \/>\none or more agents of the Trustee located in the State of New York; and (e) one<br \/>\nor more agents of the<\/p>\n<\/p>\n<p align=\"center\">A-5<\/p>\n<p align=\"center\">\n<hr>\n<p>Trustee located in the State of New York are anticipated to be involved in<br \/>\nthe performance of the Trustee153s obligations under the Indenture.<\/p>\n<\/p>\n<p>On the basis of the foregoing, and subject to the assumptions, exceptions,<br \/>\nlimitations and qualifications stated herein, we are of the opinion that:<\/p>\n<\/p>\n<p>1. The execution, delivery and performance of the Transaction Agreements by<br \/>\nthe Company have been duly authorized by all necessary corporate action on the<br \/>\npart of the Company.<\/p>\n<\/p>\n<p>2. The execution, delivery and performance by the Company on the date hereof<br \/>\nof its obligations under the Agreement, the Indenture and the Firm Notes do not<br \/>\n(a) violate the Charter or the Bylaws, (b) violate any judgment, writ, decree or<br \/>\norder of any court listed on Exhibit B hereto to which the Company is named as a<br \/>\nparty, (c) constitute a breach or default by the Company under the Company<br \/>\nContracts, except where such breach or default would not have a material adverse<br \/>\neffect on the Company; or (d) violate any Applicable Law, except any violation<br \/>\nthat would not have a material adverse effect on the Company, and subject to the<br \/>\nexceptions stated in paragraphs 4(i) through 4(xxiii) below.<\/p>\n<\/p>\n<p>3. The statements relating to the terms of the Firm Notes and the Indenture<br \/>\nin the Time of Sale Memorandum and the Final Memorandum under the caption<br \/>\n&#8220;Description of Notes,&#8221; insofar as such statements constitute summaries of legal<br \/>\nmatters or documents referred to therein, fairly summarize in all material<br \/>\nrespects such matters and documents. The Firm Notes, when executed and<br \/>\nauthenticated in accordance with the provisions of the Indenture and delivered<br \/>\nto and paid for by the Initial Purchasers in accordance with the terms of the<br \/>\nAgreement, will be valid and binding obligations of the Company, enforceable in<br \/>\naccordance with their terms, except as the validity, binding nature or<br \/>\nenforceability of the same may be limited by the exceptions stated in paragraphs<br \/>\n4(i) through 4(xxiii) below.<\/p>\n<\/p>\n<p>4. The Agreement and the Indenture have been duly executed and delivered by<br \/>\nthe Company. The Indenture constitutes a valid and binding obligation of the<br \/>\nCompany, enforceable against the Company in accordance with its terms, except as<br \/>\nthe validity, binding nature or enforceability of the same may be limited by:\n<\/p>\n<\/p>\n<p>(i) applicable federal or state bankruptcy, insolvency, reorganization,<br \/>\narrangement, moratorium, fraudulent transfer or conveyance, and other laws or<br \/>\ncourt decisions relating to or affecting the rights of creditors;<\/p>\n<\/p>\n<p align=\"center\">A-6<\/p>\n<p align=\"center\">\n<hr>\n<p>(ii) equitable principles of general applicability (including, without<br \/>\nlimitation, concepts of materiality, reasonableness, good faith and fair<br \/>\ndealing, equitable subordination, and the possible unavailability of specific<br \/>\nperformance or injunctive relief), regardless of whether considered in a<br \/>\nproceeding in equity or at law or whether codified by statute;<\/p>\n<\/p>\n<p>(iii) California judicial decisions which have held that certain provisions,<br \/>\nincluding without limitation those providing for the acceleration of<br \/>\nindebtedness upon the occurrence of specified events, are unenforceable under<br \/>\ncircumstances where it cannot be demonstrated that the enforcement of such<br \/>\nprovisions (a) is reasonably necessary for the protection of the party seeking<br \/>\nenforcement, (b) has been undertaken in good faith under the circumstances then<br \/>\nexisting, and (c) is commercially reasonable;<\/p>\n<\/p>\n<p>(iv) the effect of Section 1670.5 of the California Civil Code, which<br \/>\nprovides that a court may refuse to enforce a contract or limit the application<br \/>\nthereof or of any clause thereof which the court finds as a matter of law to<br \/>\nhave been unconscionable at the time it was made;<\/p>\n<\/p>\n<p>(v) the unenforceability, under certain circumstances, of provisions that<br \/>\ncontain prospective waivers of (a) vaguely or broadly stated rights, (b) unknown<br \/>\nfuture rights, (c) the benefits of statutory, regulatory or constitutional<br \/>\nrights, unless and to the extent the statute, regulation or constitution<br \/>\nexplicitly permits such waiver, (d) unknown future defenses and (e) rights to<br \/>\ndamages;<\/p>\n<\/p>\n<p>(vi) the unenforceability of provisions prohibiting waivers that are not in<br \/>\nwriting to the extent that Section 1698 of the California Civil Code (or similar<br \/>\nprovisions of other applicable laws) permits oral modifications that have been<br \/>\nperformed;<\/p>\n<\/p>\n<p>(vii) the unenforceability, under certain circumstances, of provisions to the<br \/>\neffect that rights or remedies are not exclusive, that every right or remedy is<br \/>\ncumulative and may be exercised in addition to or with any other right or<br \/>\nremedy, or that the election of some particular remedy or remedies does not<br \/>\npreclude recourse to one or another remedy;<\/p>\n<\/p>\n<p>(viii) the potential to vary the terms of the Indenture on the basis of parol<br \/>\nevidence;<\/p>\n<\/p>\n<p align=\"center\">A-7<\/p>\n<p align=\"center\">\n<hr>\n<p>(ix) limitations on the enforceability of indemnification, release,<br \/>\ncontribution, exculpatory or nonliability provisions under federal or state<br \/>\nsecurities laws, under Sections 1542, 1543 and 2772-78 of the California Civil<br \/>\nCode, and under any other applicable statute or court decisions, including,<br \/>\nwithout limitation, the effect of California statutes and cases applying such<br \/>\nstatutes which have denied enforcement of indemnification agreements against the<br \/>\nindemnitee153s negligence, wrongdoing or violation of law;<\/p>\n<\/p>\n<p>(x) the effect of Section 1717, et seq. of the California Civil Code and<br \/>\njudicial decisions thereunder on provisions which purport to require the award<br \/>\nof attorneys153 fees, expenses or costs;<\/p>\n<\/p>\n<p>(xi) the unenforceability, under certain circumstances, of provisions which<br \/>\ndirectly or indirectly purport to effect a jury trial waiver;<\/p>\n<\/p>\n<p>(xii) the unenforceability, under certain circumstances, of arbitration or<br \/>\nother alternative dispute resolution provisions;<\/p>\n<\/p>\n<p>(xiii) the unenforceability, under certain circumstances, of provisions which<br \/>\npurport to govern forum selection, venue, personal jurisdiction or subject<br \/>\nmatter jurisdiction;<\/p>\n<\/p>\n<p>(xiv) the unenforceability, under certain circumstances, of provisions which<br \/>\npurport to appoint a party as attorney-in-fact or agent for an adverse party;\n<\/p>\n<\/p>\n<p>(xv) the effect of Section 23301, et seq. of the California Revenue and<br \/>\nTaxation Code, which provides that a party to a contract may, under certain<br \/>\ncircumstances, void the contract if the other party (irrespective of the<br \/>\njurisdiction of organization or domicile of such other party) fails to file any<br \/>\nrequired California tax returns and\/or pay any required California franchise or<br \/>\nincome taxes;<\/p>\n<\/p>\n<p>(xvi) the effect of Section 564 of the California Code of Civil Procedure and<br \/>\nother provisions of California law which impose certain restrictions on the<br \/>\nenforceability of provisions that provide for the appointment of a receiver;\n<\/p>\n<\/p>\n<p>(xvii) the unenforceability, under certain circumstances, of provisions which<br \/>\npurport to authorize a judicial referee to order injunctive or other provisional<br \/>\nor similar extraordinary relief;<\/p>\n<\/p>\n<p align=\"center\">A-8<\/p>\n<p align=\"center\">\n<hr>\n<p>(xviii) the unenforceability of provisions concerning offsets, self-help or<br \/>\nsummary remedies, to the extent that enforcement of such provisions is<br \/>\ndetermined by a court to be unreasonable under then existing circumstances;<\/p>\n<\/p>\n<p>(xix) the unenforceability, under certain circumstances, of provisions which<br \/>\nprovide for penalties, liquidated damages, acceleration of future amounts due<br \/>\n(other than principal) without appropriate discount to present value, prepayment<br \/>\ncharges, late charges, additional interest in the event of a default or fees or<br \/>\ncosts related to such charges;<\/p>\n<\/p>\n<p>(xx) the effect of Sections 3275 and 3302 of the California Civil Code and<br \/>\nother provisions of California law which impose limitations on the<br \/>\nenforceability of time-is-of-the-essence clauses;<\/p>\n<\/p>\n<p>(xxi) without limiting the generality of subparagraph (v) above, the effect<br \/>\nof <u>Union Bank v. Gradsky<\/u>, 265 Cal. App. 2d 40 (1968), and <u>Cathay Bank<br \/>\nv. Lee<\/u>, 14 Cal. App. 4th 1533 (1993) and their progeny, which impose certain<br \/>\nlimitations upon the effectiveness of waivers;<\/p>\n<\/p>\n<p>(xxii) the unenforceability, under certain circumstances, of provisions of<br \/>\nagreements purporting to establish evidentiary standards or to render<br \/>\ndeterminations by any party conclusive; and<\/p>\n<\/p>\n<p>(xxiii) the effect of the restrictions in Article XV of the Constitution of<br \/>\nthe State of California upon provisions relating to rates of interest on the<br \/>\nloan of money.<\/p>\n<\/p>\n<p>5. The shares of Common Stock of the Company that are issuable pursuant to<br \/>\nand upon conversion of the Firm Notes as provided in the Indenture and the Firm<br \/>\nNotes (the &#8220;<strong><em>Shares<\/em><\/strong>&#8220;) have been duly authorized and<br \/>\nreserved in accordance with the Resolutions, assuming such conversion takes<br \/>\nplace immediately following the closing on the Closing Date. The Shares, when<br \/>\nissued and delivered upon conversion of the Firm Notes in accordance with the<br \/>\nterms of such Firm Notes and the Indenture, will be validly issued, fully paid<br \/>\nand nonassessable. The stockholders of the Company have no preemptive rights<br \/>\nunder the Charter, the Bylaws or the DGCL.<\/p>\n<\/p>\n<p>6. The sale of the Firm Notes pursuant to the Agreement constitutes a<br \/>\ntransaction exempt from the registration requirements under Section 5 of the<br \/>\nSecurities Act and does not require qualification of an indenture in respect<br \/>\nthereof under the Trust Indenture Act of 1939, as amended.<\/p>\n<\/p>\n<p align=\"center\">A-9<\/p>\n<p align=\"center\">\n<hr>\n<p>7. No consent, approval or authorization of, or designation, declaration or<br \/>\nfiling with, any California or federal governmental authority is required by the<br \/>\nCompany under any Applicable Law in connection with the execution, delivery and<br \/>\nperformance by the Company of the Transaction Agreements in accordance with<br \/>\ntheir respective terms other than: (i) those that have already been obtained and<br \/>\nare in full force and effect; or (ii) as required by state securities or Blue<br \/>\nSky laws, as to which we express no opinion.<\/p>\n<\/p>\n<p>8. The Company is not, and will not become as a result of the consummation of<br \/>\nthe transactions contemplated by the Agreement, an &#8220;investment company&#8221; as<br \/>\ndefined in the 1940 Act.<\/p>\n<\/p>\n<p>9. The statements in the Time of Sale Memorandum and the Final Memorandum<br \/>\nunder the caption &#8220;Material U.S. Federal Tax Considerations,&#8221; insofar as such<br \/>\nstatements purport to constitute a summary of the consequences to certain<br \/>\nholders under the United States federal tax laws referred to therein, are<br \/>\naccurate and fairly summarize such consequences in all material respects.<\/p>\n<\/p>\n<p>10. The statements in the Time of Sale Memorandum and the Final Memorandum<br \/>\nunder the caption &#8220;Description of Capital Stock,&#8221; insofar as such statements<br \/>\nconstitute summaries of the legal matters or documents referred to therein,<br \/>\nfairly summarize the matters referred to therein in all material respects.<\/p>\n<\/p>\n<p>11. Assuming a court of the State of California has jurisdiction, in a<br \/>\nproceeding in a court of the State of California for the enforcement of the<br \/>\nIndenture, the court should, assuming that Section 18.04 of the Indenture<br \/>\nproviding for the choice of New York law to govern the Indenture and the Firm<br \/>\nNotes is enforceable under the laws of New York, give effect to Section 18.04 of<br \/>\nthe Indenture, except to the extent that (i) any provision of the Indenture is<br \/>\ndetermined by the court to be contrary to a fundamental policy of the state<br \/>\nwhose law would apply in the absence of that Section, and (ii) that state has a<br \/>\nmaterially greater interest in the determination of the particular issue than<br \/>\ndoes the state whose law is chosen.<\/p>\n<\/p>\n<p>In connection with the preparation of the Time of Sale Memorandum and the<br \/>\nFinal Memorandum, we have participated in conferences with officers and other<br \/>\nrepresentatives of the Company, representatives of the independent public<br \/>\naccountants of the Company and representatives of the Initial Purchasers,<br \/>\nincluding its counsel, at which the contents of the Time of Sale Memorandum and<br \/>\nthe Final Memorandum were discussed. Although we have not independently<br \/>\nverified, are not passing upon and do not assume responsibility for the<br \/>\naccuracy, completeness or fairness of the statements contained in the Time of<br \/>\nSale Memorandum or the Final Memorandum or any amendments or supplements<br \/>\nthereto, except as described above in the first sentence of paragraph 3 and in\n<\/p>\n<\/p>\n<p align=\"center\">A-10<\/p>\n<p align=\"center\">\n<hr>\n<p>paragraphs 9 and 10, on the basis of the foregoing, nothing has come to our<br \/>\nattention that causes us to believe that: (A) the Time of Sale Memorandum (other<br \/>\nthan financial statements, schedules and notes and other financial information<br \/>\nincluded or incorporated by reference therein or derived therefrom, as to which<br \/>\nwe express no comment), as of its date or as of the date hereof, contained or<br \/>\ncontains an untrue statement of a material fact or omitted or omits to state a<br \/>\nmaterial fact required to be stated therein or necessary to make the statements<br \/>\ntherein, in light of the circumstances under which they were made, not<br \/>\nmisleading or (B) the Final Memorandum (other than financial statements,<br \/>\nschedules and notes and other financial information included or incorporated by<br \/>\nreference therein or derived therefrom, as to which we express no comment), as<br \/>\nof its date or as of the date hereof, contained or contains an untrue statement<br \/>\nof a material fact or omitted or omits to state a material fact required to be<br \/>\nstated therein or necessary to make the statements therein, in light of the<br \/>\ncircumstances under which they were made, not misleading.<\/p>\n<\/p>\n<p>Our opinions pertain only to the Transaction Agreements themselves, and do<br \/>\nnot encompass, cover or pertain to, or take into account the potential effect on<br \/>\nthe opinions rendered above of, any agreement attached as a schedule or an<br \/>\nexhibit to the Transaction Agreements, referred to in the Transaction Agreements<br \/>\nor executed contemporaneously with the Transaction Agreements.<\/p>\n<\/p>\n<p>In rendering our opinions, we have assumed that the parties have acted and<br \/>\nwill act in accordance with the express terms of the Transaction Agreements and<br \/>\nthe rights and obligations of the parties thereunder, and we express no opinion<br \/>\nwith respect to the effect of any party153s failure to so comply or act.<\/p>\n<\/p>\n<p>Notwithstanding anything in this opinion letter to the contrary, the opinions<br \/>\nset forth above are given only as of the date hereof. We disclaim any obligation<br \/>\nto update any of the opinions rendered herein and express no opinion as to the<br \/>\neffect of events occurring, circumstances arising, or changes of law becoming<br \/>\neffective or occurring, after the date hereof on the matters addressed in this<br \/>\nopinion letter, and we assume no responsibility to inform you of additional or<br \/>\nchanged facts, or changes in law, of which we may become aware.<\/p>\n<\/p>\n<p align=\"center\">A-11<\/p>\n<p align=\"center\">\n<hr>\n<p>The opinions set forth above are expressly limited to the matters stated. No<br \/>\nopinion is implied or may be inferred beyond what is explicitly stated in this<br \/>\nletter. This letter is rendered solely for your benefit in connection with the<br \/>\ntransactions contemplated by the Transaction Agreements and may not be relied<br \/>\nupon by any other party. Copies of this letter may not be circulated or<br \/>\nfurnished to any other person or entity (except your attorneys and other<br \/>\nadvisors) and this letter may not be referred to in any report or document<br \/>\nfurnished to any other person or entity, without our prior written consent.<\/p>\n<\/p>\n<p>Very truly yours,<\/p>\n<\/p>\n<p>HOWARD RICE NEMEROVSKI CANADY <br \/>\nFALK &amp; RABKIN <br \/>\nA Professional Corporation<\/p>\n<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<td width=\"48%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td colspan=\"2\"><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\">\n<p>Julia Vax<\/p>\n<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">A-12<\/p>\n<p align=\"center\">\n<hr>\n<p align=\"center\"><u>Exhibit A<\/u> <br \/>\nCompany Contracts<\/p>\n<p align=\"center\">\n<p>1. Indenture dated as of June 1, 2004, between the Company and Wells Fargo<br \/>\nBank, N.A. as trustee, including therein the form of the Note.<\/p>\n<\/p>\n<p>2. Form of Indemnity Agreement between the Company and each of its directors<br \/>\nand executive officers.<\/p>\n<\/p>\n<p>3. Consent to Assignment and Assumption of Lease dated April 22, 1998 between<br \/>\nCSM Investors, Inc., IntraNet Integration Group, Inc. and the Company.<\/p>\n<\/p>\n<p>4. Assignment of Lease dated April 21, 1998 between Intranet Integration<br \/>\nGroup, Inc. and the Company.<\/p>\n<\/p>\n<p>5. Lease Agreement dated January 18, 2000 between Property Reserve, Inc. and<br \/>\nthe Company.<\/p>\n<\/p>\n<p>6. First Amendment of Lease dated January 31, 2001 to that certain Lease<br \/>\ndated April 24, 1996 between CSM Investors, Inc. and the Company (as assignee of<br \/>\nIntranet Integration Group, Inc.).<\/p>\n<\/p>\n<p>7. 1998 Stock Option Plan, as amended and superseded by 1998 Equity Incentive<br \/>\nPlan.<\/p>\n<\/p>\n<p>8. 1999 Stock Option Plan, formerly known as the 1999 Non-Officer Stock<br \/>\nOption Plan, as amended.<\/p>\n<\/p>\n<p>9. 2000 Employee Stock Purchase Plan, as amended, and offering.<\/p>\n<\/p>\n<p>10. Second Amendment of Lease dated April 22, 2002 to that certain Lease<br \/>\ndated April 24, 1996 between CSM Investors, Inc. and the Company (as assignee of<br \/>\nIntranet Integration Group, Inc.) as amended.<\/p>\n<\/p>\n<p>11. Second Amendment of Lease dated April 28, 2003 to that certain Lease<br \/>\ndated January 18, 2000 between Property Reserve Inc. and the Company.<\/p>\n<\/p>\n<p>12. Registration Rights Agreement dated as of June 1, 2004, between the<br \/>\nCompany and the initial purchasers of Senior Convertible Notes due January 1,<br \/>\n2024.<\/p>\n<\/p>\n<p align=\"center\">A-13<\/p>\n<p align=\"center\">\n<hr>\n<p>13. Second Amended and Restated Symantec Online Store Agreement, between<br \/>\nSymantec Corporation, Symantec Limited, the Company. and Digital River Ireland<br \/>\nLimited effective April 1, 2006.<\/p>\n<\/p>\n<p>14. 1998 Equity Incentive Plan (formerly known as 1998 Stock Option Plan)<br \/>\neffective March 4, 2008.<\/p>\n<\/p>\n<p>15. Amended and Restated Employment Agreement for Joel A. Ronning dated<br \/>\nFebruary 28, 2007.<\/p>\n<\/p>\n<p>16. Change of Control and Severance Agreement for Thomas M. Donnelly<br \/>\neffective March 4, 2008.<\/p>\n<\/p>\n<p>17. Form of Amendment to Non-Qualified Stock Option Agreement.<\/p>\n<\/p>\n<p>18. Inducement Equity Incentive Plan effective December 15, 2005. .<\/p>\n<\/p>\n<p>19. 2007 Equity Incentive Plan.<\/p>\n<\/p>\n<p>20. Change of Control and Severance Agreement for Kevin L. Crudden dated<br \/>\nMarch 4, 2008.<\/p>\n<\/p>\n<p>21. Microsoft Operations Digital Distribution Agreement, between the Company<br \/>\nand Microsoft Corporation effective September 1, 2006.<\/p>\n<\/p>\n<p>22. Direct Reseller Addendum to the Microsoft Operations Digital Distribution<br \/>\nAgreement, between the Company and Microsoft Corporation effective September 1,<br \/>\n2006.<\/p>\n<\/p>\n<p>23. Omnibus Amendment to the Microsoft Operations Digital Distribution<br \/>\nAgreement, between the Company and Microsoft Corporation effective October 4,<br \/>\n2007.<\/p>\n<\/p>\n<p>24. Amendment to the Microsoft Operations Digital Distribution Agreement,<br \/>\nbetween the Company. and Microsoft Corporation effective December 2, 2008.<\/p>\n<\/p>\n<p>25. Amendment to the Microsoft Operations Digital Distribution Agreement,<br \/>\nbetween the Company and Microsoft Corporation effective September 9, 2009.<\/p>\n<\/p>\n<p>26. Second Omnibus Amendment to the Microsoft Operations Digital Distribution<br \/>\nAgreement between the Company and Microsoft Corporation effective August 20,<br \/>\n2010.<\/p>\n<\/p>\n<p align=\"center\">A-14<\/p>\n<p align=\"center\">\n<hr>\n<p align=\"right\"><strong>EXHIBIT B<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>OPINION OF KEVIN CRUDDEN, VICE PRESIDENT AND <br \/>\nGENERAL COUNSEL OF THE COMPANY<\/strong><\/p>\n<p align=\"center\">\n<p align=\"center\">[Digital River, Inc. Letterhead]<\/p>\n<p align=\"center\">\n<p align=\"right\">November ___, 2010<\/p>\n<p align=\"right\">\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nMorgan Stanley &amp; Co. Incorporated <br \/>\nAs Representatives of the Initial Purchasers<\/p>\n<\/p>\n<p>c\/o Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nOne Bryant Park <br \/>\nNew York, NY 10036<\/p>\n<\/p>\n<p>c\/o Morgan Stanley &amp; Co. Incorporated <br \/>\n1585 Broadway <br \/>\nNew York, NY 10036<\/p>\n<\/p>\n<p><strong>Re: <u>Digital River, Inc.<\/u><\/strong><\/p>\n<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<\/p>\n<p>I am Vice President and General Counsel of Digital River, Inc., a Delaware<br \/>\ncorporation (the &#8220;<strong><em>Company<\/em><\/strong>&#8220;).<\/p>\n<\/p>\n<p>This opinion is rendered to you at the request of the Company pursuant to<br \/>\nSection 5(d) of the Purchase Agreement dated October 26, 2010 (the<br \/>\n&#8220;<strong><em>Agreement<\/em><\/strong>&#8220;), by and among you, as representatives of<br \/>\nthe several Initial Purchasers named therein, and the Company regarding the<br \/>\noffering of up to $300,000,000 aggregate principal amount of 2.00% Convertible<br \/>\nSenior Notes due 2030. Capitalized terms used but not defined herein have the<br \/>\nsame meanings given them in the Agreement.<\/p>\n<\/p>\n<p>In this connection, I have examined original or copies of the following<br \/>\ndocuments, each of which is dated the date hereof (unless otherwise specified):\n<\/p>\n<\/p>\n<p>1. The Time of Sale Memorandum for the Firm Notes (as defined below) dated<br \/>\nOctober 26, 2010 (the &#8220;<strong><em>Time of Sale Memorandum<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p align=\"center\">B-1<\/p>\n<p align=\"center\">\n<hr>\n<p>2. The Final Memorandum for the Firm Notes dated October [26], 2010 (the<br \/>\n&#8220;<strong><em>Final Memorandum<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>3. The Agreement;<\/p>\n<\/p>\n<p>4. The Indenture dated November 1, 2010 between the Company and Wells Fargo<br \/>\nBank, N.A. as trustee (the &#8220;<strong><em>Trustee<\/em><\/strong>&#8220;) (the<br \/>\n&#8220;<strong><em>Indenture<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>5. The 2.00% Convertible Senior Notes dated November 1, 2010, issued by the<br \/>\nCompany in favor of the Initial Purchasers pursuant to the Agreement as of the<br \/>\ndate hereof (the <strong><em>&#8220;Firm Notes<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>6. The Company153s Amended and Restated Certificate of Incorporation, filed<br \/>\nwith the Secretary of State of Delaware on August 14, 1998, as amended by the<br \/>\nCertificates of Amendment, filed on September 20, 2000 and May 31, 2006 (the<br \/>\n&#8220;<strong><em>Charter<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>7. The Company153s Amended and Restated Bylaws as currently in effect (the<br \/>\n&#8220;<strong><em>Bylaws<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>8. The resolutions of the Board of Directors of the Company adopted on<br \/>\nOctober 22, 2010 and the resolutions of the Negotiating Committee of the Board<br \/>\nof Directors adopted on October 26, 2010 (the<br \/>\n&#8220;<strong><em>Resolutions<\/em><\/strong>&#8220;).<\/p>\n<\/p>\n<p>9. Certificates, each dated as of a recent date, from the Secretaries of<br \/>\nState of the States of Delaware, California, Minnesota and Washington as to the<br \/>\ngood standing of the Company in such states, and a certificate, dated as of a<br \/>\nrecent date, from the Secretary of State of the State of California as to the<br \/>\ngood standing of BlueHornet Networks, Inc. in such state (collectively,<br \/>\n&#8220;<strong><em>Domestic Good Standings<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>10. Certificates, each dated as of a recent date, from the Register of<br \/>\nCompanies of the Companies Registration Office of Ireland, as to the status of<br \/>\nDigital River Technology Limited and the status of Digital River Ireland Limited<br \/>\nin that country, and from Handelsregister B of the Cologne District Office, as<br \/>\nto the status of Digital River GmbH in that country (collectively,<br \/>\n&#8220;<strong><em>Foreign Good Standings<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>11. The Company153s Annual Report on Form 10-K (the &#8220;<strong><em>Form<br \/>\n10-K<\/em><\/strong>&#8220;) filed with the Commission for the year ended December 31,<br \/>\n2009, as amended on August 19, 2010 pursuant to the Securities Exchange Act of<br \/>\n1934 (the &#8220;<strong><em>Exchange Act<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p align=\"center\">B-2<\/p>\n<p align=\"center\">\n<hr>\n<p>12. The Company153s Quarterly Reports on Form 10-Q (the &#8220;<strong><em>Form<br \/>\n10-Qs<\/em><\/strong>&#8220;) filed with the Commission for the quarters ended March 31,<br \/>\n2010 and June 30, 2010;<\/p>\n<\/p>\n<p>13. The Company153s Current Reports on Form 8-K and Form 8-K\/A (the<br \/>\n&#8220;<strong><em>Form 8-Ks<\/em><\/strong>&#8220;) filed with the Commission from January<br \/>\n28, 2010 to the date hereof;<\/p>\n<\/p>\n<p>14. The Company153s 2010 Proxy Statement filed with the Commission on March 30,<br \/>\n2010 (together with the Form 10-K, the Form 10-Qs, the Form 8-Ks, the<br \/>\n&#8220;<strong><em>Exchange Act Reports<\/em><\/strong>&#8220;);<\/p>\n<\/p>\n<p>15. The Company153s Registration Statement on Form 8-A, as filed on July 20,<br \/>\n1998;<\/p>\n<\/p>\n<p>16. The minute books of the Company;<\/p>\n<\/p>\n<p>17. The minute books of each of the Significant Subsidiaries (as defined<br \/>\nbelow);<\/p>\n<\/p>\n<p>18. Such corporate records, certificates and other documents (of which I am<br \/>\naware) and such questions of law as I have considered necessary or appropriate<br \/>\nfor the purposes of rendering the opinions that follow.<\/p>\n<\/p>\n<p>The agreements and documents described in Items 3 through 5 above are<br \/>\nreferred to herein as the &#8220;<strong><em>Transaction Agreements<\/em><\/strong>.&#8221;\n<\/p>\n<\/p>\n<p>The opinions set forth below are subject to the following:<\/p>\n<\/p>\n<p>(i) My opinion in paragraph 1 below is based solely on my review of a<br \/>\ncertified copy of the Charter and copies of the Bylaws, the minute books of the<br \/>\nCompany, and the Domestic Good Standings.<\/p>\n<\/p>\n<p>(ii) My opinion in paragraph 2 below is based solely on my review of the<br \/>\nForeign Good Standings, and the minute books of each Significant Subsidiary (as<br \/>\ndefined below).<\/p>\n<\/p>\n<p>(iii) My opinion in paragraph 5 below is based solely on my personal actual<br \/>\nknowledge and the docket or complaint searches in the following jurisdictions<br \/>\nand databases: (a) Courtlink (courtlink.lexisnexis.com) for the dockets of the<br \/>\nDelaware Court of Chancery; (b) the U.S. Party\/Case Index<br \/>\n(pacer.uspci.uscourts.gov) for the dockets of civil cases in federal district<br \/>\ncourts in which the Company is named as a party; and (c) Westlaw<br \/>\n(<u>www.westlaw.com<\/u>) for the dockets of the Minnesota Supreme Court, Court<br \/>\nof Appeals, District<\/p>\n<\/p>\n<p align=\"center\">B-3<\/p>\n<p align=\"center\">\n<hr>\n<p>Courts, Tax Court and Workers153 Compensation Court of Appeals in which the<br \/>\nCompany is named as a party.<\/p>\n<\/p>\n<p>In giving the opinions that follow I have relied as to matters of fact<br \/>\nwithout investigation, to the extent I deemed proper, upon certificates from<br \/>\nofficers of the Company and certain of its affiliates, and one or more<br \/>\ncertificates, facsimiles, and other documents from, and oral conversations with,<br \/>\npublic officials. I have assumed without investigation the authenticity of each<br \/>\ndocument submitted to me as an original, the conformity to the originals of each<br \/>\ndocument submitted to me as a copy, the authenticity of the originals of such<br \/>\nlatter documents, the genuineness of all signatures, and the legal capacity of<br \/>\nall natural persons.<\/p>\n<\/p>\n<p>Based on and subject to the foregoing, it is my opinion that:<\/p>\n<\/p>\n<p>1. The Company has been duly incorporated, is a validly existing corporation<br \/>\nin good standing under the laws of the State of Delaware, has the corporate<br \/>\npower and authority to own its property and conduct its business as described in<br \/>\nthe Time of Sale Memorandum, and is duly qualified to transact business as a<br \/>\nforeign corporation in the states of California, Minnesota and Washington.<\/p>\n<\/p>\n<p>2. Each of BlueHornet Networks, Inc., Digital River GmbH, Digital River<br \/>\nTechnology Limited and Digital River Ireland Limited (together, the<br \/>\n&#8220;<strong><em>Significant Subsidaries<\/em><\/strong>&#8220;) is in good standing (or a<br \/>\nforeign country equivalent thereof) under the laws of the jurisdiction of its<br \/>\nincorporation; all of the issued shares of capital stock of each Significant<br \/>\nSubsidiary are owned directly or indirectly by the Company, free and clear of<br \/>\nall liens, encumberances, equities or claims.<\/p>\n<\/p>\n<p>3. The shares of Common Stock of the Company outstanding as of the Closing<br \/>\nDate have been duly authorized and validly issued, and are fully paid and non<br \/>\nassessable.<\/p>\n<\/p>\n<p>4. The statements (a) in &#8220;Item 3 : Legal Proceedings&#8221; of the Company153s Form<br \/>\n10-K for the year ended December 31, 2009, (b) in &#8220;Item 1 : Legal Proceedings&#8221;<br \/>\nof Part II of the Company153s quarterly reports on Form 10-Q for the quarters<br \/>\nended March 31, 2010 and June 30, 2010 and (c) in &#8220;Item 8.01 : Other Events&#8221; in<br \/>\neach current report on Form 8-K included or incorporated by reference in the<br \/>\nTime of Sale Memorandum and in the Final Memorandum, in each case insofar as<br \/>\nsuch statements constitute summaries of the legal matters, documents or<br \/>\nproceedings referred to therein, as of the respective filing dates thereof,<br \/>\nfairly summarizesuch legal matters, documents and proceedings in all material<br \/>\nrespects.<\/p>\n<\/p>\n<p align=\"center\">B-4<\/p>\n<p align=\"center\">\n<hr>\n<p>5. Except as included or incorporated by reference in the Time of Sale<br \/>\nMemorandum, I do not know of any legal or governmental proceedings pending or<br \/>\nthreatened to which the Company or any of its subsidiaries is a party or to<br \/>\nwhich any of the properties of the Company or any of its subsidiaries is subject<br \/>\nthat would reasonably be expected to result in a material adverse effect on the<br \/>\nCompany and its subsidiaries, taken as a whole, or on the Company153s ability to<br \/>\nperform its obligations under the Transaction Agreements or to consummate the<br \/>\ntransactions contemplated by the Time of Sale Memorandum.<\/p>\n<\/p>\n<p>6. The Exchange Act Reports or portions thereof incorporated by reference in<br \/>\nthe Time of Sale Memorandum or Final Memorandum comply as to form in all<br \/>\nmaterial respects with the requirements of the Exchange Act and the applicable<br \/>\nrules and regulations thereunder; provided, however, that I express no view as<br \/>\nto the financial statements, schedules and notes and other financial information<br \/>\nincluded therein or derived therefrom.<\/p>\n<\/p>\n<p>The opinions expressed herein are given as of the date hereof only, and are<br \/>\nnot given as of any later date. I have not undertaken any factual or legal<br \/>\ninvestigation beyond the date hereof, and I disclaim any obligation to notify<br \/>\nyou or any other person after the date hereof if any change in fact and\/or law<br \/>\nshould change my opinion with respect to any matters set forth herein.<\/p>\n<\/p>\n<p>I am a member of the bar of the State of Minnesota. I express no opinion as<br \/>\nto any laws of any other jurisdiction other than the laws of the State of<br \/>\nDelaware and federal laws of the United States to the extent applicable to the<br \/>\nscope of the opinions expressed above. Further, I express no opinion regarding<br \/>\nchoice of law or conflicts of laws.<\/p>\n<\/p>\n<p>This opinion is rendered to you as the Initial Purchasers under the Agreement<br \/>\nand may not be relied upon for any other purpose or by any other person without<br \/>\nmy express written consent.<\/p>\n<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td colspan=\"3\">\n<p>Very truly yours,<\/p>\n<p>Kevin L. Crudden <br \/>\nVice President and General Counsel<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">B-5<\/p>\n<p align=\"center\">\n<hr>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"right\"><strong>EXHIBIT C<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>OPINION OF DAVIS POLK &amp; WARDWELL LLP<\/strong><\/p>\n<p align=\"center\">\n<p>The opinion of Davis Polk &amp; Wardwell LLP to be delivered pursuant to<br \/>\nSection 5(d) of the Purchase Agreement shall be to the effect that:<\/p>\n<\/p>\n<p>A. The Purchase Agreement has been duly authorized, executed and delivered by<br \/>\nthe Company.<\/p>\n<\/p>\n<p>B. The Securities have been duly authorized by the Company and, when executed<br \/>\nand authenticated in accordance with the provisions of the Indenture and<br \/>\ndelivered to and paid for by the Initial Purchasers in accordance with the terms<br \/>\nof the Purchase Agreement, will be valid and binding obligations of the Company,<br \/>\nenforceable in accordance with their terms, subject to applicable bankruptcy,<br \/>\ninsolvency and similar laws affecting creditors153 rights generally, concepts of<br \/>\nreasonableness and equitable principles of general applicability, and will be<br \/>\nentitled to the benefits of the Indenture pursuant to which such Securities are<br \/>\nto be issued.<\/p>\n<\/p>\n<p>C. The Underlying Securities issuable upon conversion of the Securities have<br \/>\nbeen duly authorized and reserved and, when issued upon conversion of the<br \/>\nSecurities in accordance with the terms of the Securities, will be validly<br \/>\nissued, fully paid and non-assessable, and the issuance of the Underlying<br \/>\nSecurities will not be subject to any preemptive or similar rights.<\/p>\n<\/p>\n<p>D. The Indenture has been duly authorized, executed and delivered by, and is<br \/>\na valid and binding agreement of, the Company, enforceable in accordance with<br \/>\nits terms, subject to applicable bankruptcy, insolvency and similar laws<br \/>\naffecting creditors153 rights generally, concepts of reasonableness and equitable<br \/>\nprinciples of general applicability.<\/p>\n<\/p>\n<p>E. The statements relating to legal matters, documents or proceedings<br \/>\nincluded in (1) the Time of Sale Memorandum and the Final Memorandum under the<br \/>\ncaptions &#8220;Description of Securities&#8221;, &#8220;Description of Capital Stock&#8221; and<br \/>\n&#8220;Transfer Restrictions&#8221; and (2) in the Final Memorandum under the caption &#8220;Plan<br \/>\nof Distribution&#8221; in each case fairly summarize in all material respects such<br \/>\nmatters, documents and proceedings.<\/p>\n<\/p>\n<p>F. Nothing has come to the attention of such counsel to cause such counsel to<br \/>\nbelieve that (i) the Time of Sale Memorandum (except for the financial<br \/>\nstatements and financial schedules and other financial data, as to which such<br \/>\ncounsel need not express any belief) as of the date of the Purchase Agreement or<br \/>\nas amended or supplemented, if applicable, as of the date such opinion is<br \/>\ndelivered contained or contains any untrue statement of a material fact or<br \/>\nomitted<\/p>\n<\/p>\n<p align=\"center\">C-1<\/p>\n<p align=\"center\">\n<hr>\n<p>or omits to state a material fact necessary in order to make the statements<br \/>\ntherein, in the light of the circumstances under which they were made, not<br \/>\nmisleading or (ii) the Final Memorandum (except for the financial statements and<br \/>\nfinancial schedules and other financial and, as to which such counsel need not<br \/>\nexpress any belief) when issued contained, or as of the date such opinion is<br \/>\ndelivered, contains, any untrue statement of a material fact or omitted or omits<br \/>\nto state a material fact necessary in order to make the statements therein, in<br \/>\nthe light of the circumstances under which they were made, not misleading.<\/p>\n<\/p>\n<p>With respect to the matters referred to in the paragraph above, Davis Polk<br \/>\n&amp; Wardwell LLP may state that their beliefs are based upon their<br \/>\nparticipation in the preparation of the Time of Sale Memorandum and the Final<br \/>\nMemorandum (and any amendments or supplements thereto) and review and discussion<br \/>\nof the contents thereof (including the review of, but not participation in the<br \/>\npreparation of, the incorporated documents), but are without independent check<br \/>\nor verification except as specified.<\/p>\n<\/p>\n<p>G. Based upon the representations, warranties and agreements of the Company<br \/>\nin Sections 1(r), 1(s), 1(u), 6(h), 6(i) and 6(l) of the Purchase Agreement and<br \/>\nof the Initial Purchasers in Section 7 of the Purchase Agreement, it is not<br \/>\nnecessary in connection with the offer, sale and delivery of the Securities to<br \/>\nthe Initial Purchasers under the Purchase Agreement or in connection with the<br \/>\ninitial resale of such Securities by the Initial Purchasers in accordance with<br \/>\nSection 7 of the Purchase Agreement to register the Securities under the<br \/>\nSecurities Act of 1933 or to qualify the Indenture under the Trust Indenture Act<br \/>\nof 1939, it being understood that no opinion is expressed as to any subsequent<br \/>\nresale of any Security or Underlying Security.<\/p>\n<\/p>\n<p align=\"center\">C-2<\/p>\n<p align=\"center\">\n<hr>\n<p align=\"right\"><strong>EXHIBIT D<\/strong><\/p>\n<p align=\"right\">\n<p align=\"center\"><strong>[FORM OF LOCK-UP LETTER]<\/strong><\/p>\n<p align=\"center\">\n<p>_____________, 20___<\/p>\n<\/p>\n<p>Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nMorgan Stanley &amp; Co. Incorporated<\/p>\n<\/p>\n<p>As Representatives of the several Initial Purchasers named in Schedule I to<br \/>\nthe Purchase Agreement referred to below<\/p>\n<\/p>\n<p>c\/o Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated <br \/>\nOne Bryant Park <br \/>\nNew York, NY 10036<\/p>\n<p>c\/o Morgan Stanley &amp; Co. Incorporated <br \/>\n1585 Broadway <br \/>\nNew York, NY 10036<\/p>\n<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<\/p>\n<p>The undersigned understands that you, as Representatives of the several<br \/>\nInitial Purchasers (the &#8220;<strong>Initial Purchasers<\/strong>&#8220;) propose to enter<br \/>\ninto a Purchase Agreement (the &#8220;<strong>Purchase Agreement<\/strong>&#8220;) with<br \/>\nDigital River, Inc., a Delaware corporation (the &#8220;<strong>Company<\/strong>&#8220;),<br \/>\nproviding for the offering (the &#8220;<strong>Offering<\/strong>&#8220;) by the Company to<br \/>\nthe several Initial Purchasers of approximately $250,000,000 principal amount of<br \/>\nConvertible Senior Notes due 2030 (the &#8220;<strong>Securities<\/strong>&#8220;). The<br \/>\nSecurities will be convertible into shares of common stock, par value $0.01, of<br \/>\nthe Company (the &#8220;<strong>Common Stock<\/strong>&#8220;).<\/p>\n<\/p>\n<p>To induce the Initial Purchasers that may participate in the Offering to<br \/>\ncontinue their efforts in connection with the Offering, the undersigned hereby<br \/>\nagrees that, without the prior written consent of the Representatives on behalf<br \/>\nof the Initial Purchasers, the undersigned will not, during the period<br \/>\ncommencing on the date hereof and ending 90 days after the date of the final<br \/>\noffering memorandum relating to the Offering (the &#8220;Final Memorandum&#8221;), (1)<br \/>\noffer, pledge, sell, contract to sell, sell any option or contract to purchase,<br \/>\npurchase any option or contract to sell, grant any option, right or warrant to<br \/>\npurchase, lend, or otherwise transfer or dispose of, directly or indirectly, any<br \/>\nshares of Common Stock beneficially owned (as such term is used in Rule 13d-3 of<br \/>\nthe Securities<\/p>\n<\/p>\n<p align=\"center\">D-1<\/p>\n<p align=\"center\">\n<hr>\n<p>Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), by the undersigned or<br \/>\nany other securities so owned convertible into or exercisable or exchangeable<br \/>\nfor Common Stock or (2) enter into any swap or other arrangement that transfers<br \/>\nto another, in whole or in part, any of the economic consequences of ownership<br \/>\nof the Common Stock, whether any such transaction described in clause (1) or (2)<br \/>\nabove is to be settled by delivery of Common Stock or such other securities, in<br \/>\ncash or otherwise. The foregoing sentence shall not apply to (a) transactions<br \/>\nrelating to shares of Common Stock or other securities acquired in open market<br \/>\ntransactions after the completion of the Offering, provided that no filing under<br \/>\nSection 16(a) of the Exchange Act shall be required or shall be voluntarily made<br \/>\nin connection with subsequent sales of Common Stock or other securities acquired<br \/>\nin such open market transactions, (b) transactions relating to shares of Common<br \/>\nStock at any time if the number of shares involved in such transactions,<br \/>\ntogether with all shares of Common Stock involved in such transactions by all<br \/>\nother officers and directors; of the Company who are subject to a letter similar<br \/>\nto this letter does not in the aggregate exceed 400,000 shares of Common Stock<br \/>\nof the Company, (c) transfers of shares of Common Stock or any security<br \/>\nconvertible into Common Stock (i) to the immediate family or trust of the<br \/>\nundersigned or (ii) during the lifetime or upon death of the undersigned, by<br \/>\nbona fide gift, will or intestacy provided that in the case of any transfer or<br \/>\ndistribution pursuant to clause (c)(i) or (ii), each donee or distributee shall<br \/>\nsign and deliver a lock up letter substantially in the form of this letter, (d)<br \/>\nthe establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange<br \/>\nAct for the transfer of shares of Common Stock, provided that such plan does not<br \/>\nprovide for the transfer of Common Stock during the 90-day restricted period and<br \/>\nno public announcement or filing under the Exchange Act regarding the<br \/>\nestablishment of such plan shall be required of or voluntarily made by or on<br \/>\nbehalf of the undersigned or the Company, (e) the exercise of any options to<br \/>\nacquire shares of Common Stock pursuant to an equity incentive plan of the<br \/>\nCompany existing as of the date hereof, provided that any shares of Common Stock<br \/>\nreceived upon such exercise will be subject to the provisions and restrictions<br \/>\nherein or (f) in the case of any restricted stock or performance shares held by<br \/>\nthe undersigned that vest or are forfeited during the 90-day restricted period,<br \/>\nthe disposition of shares of such restricted stock or performance shares to the<br \/>\nCompany to pay withholding tax obligations incurred by the undersigned upon such<br \/>\nvesting (but only to such extent) or to deliver forfeited shares, provided that<br \/>\nany required filing under Section 16(a) of the Exchange Act in connection with<br \/>\nsuch disposition clearly indicates such purpose.<sup>1<\/sup> In addition, the<br \/>\nundersigned agrees that, without the prior<\/p>\n<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"3%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"96\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p><sup>1<\/sup><\/p>\n<\/td>\n<td valign=\"top\"><\/td>\n<td valign=\"top\">\n<p>The lock-up agreement for Joel Ronning, CEO, will also contain the following<br \/>\ncarve-out:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td valign=\"top\"><\/td>\n<td valign=\"top\">\n<p>&#8220;(e) the offer, sale, contract to sell, pledge dispositions or exercises by<br \/>\nthe undersigned of that certain call option, consisting of the right to purchase<br \/>\nCommon Stock, obtained by the undersigned on November 9, 2009 and expiring on<br \/>\nJanuary 22, 2011.&#8221;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">D-2<\/p>\n<p align=\"center\">\n<hr>\n<p>written consent of the Representatives on behalf of the Initial Purchasers,<br \/>\nit will not, during the period commencing on the date hereof and ending 90 days<br \/>\nafter the date of the Final Memorandum, make any demand for or exercise any<br \/>\nright with respect to, the registration of any shares of Common Stock or any<br \/>\nsecurity convertible into or exercisable or exchangeable for Common Stock. The<br \/>\nundersigned also agrees and consents to the entry of stop transfer instructions<br \/>\nwith the Company153s transfer agent and registrar against the transfer of the<br \/>\nundersigned153s shares of Common Stock except in compliance with the foregoing<br \/>\nrestrictions.<\/p>\n<\/p>\n<p>The undersigned understands that the Company and the Initial Purchasers are<br \/>\nrelying upon this agreement in proceeding toward consummation of the Offering.<br \/>\nThe undersigned further understands that this agreement is irrevocable and shall<br \/>\nbe binding upon the undersigned153s heirs, legal representatives, successors and<br \/>\nassigns. This Agreement shall lapse and become null and void if the Offering has<br \/>\nnot been consummated on or before November 30, 2010.<\/p>\n<\/p>\n<p>Whether or not the Offering actually occurs depends on a number of factors,<br \/>\nincluding market conditions. Any Offering will only be made pursuant to a<br \/>\nPurchase Agreement, the terms of which are subject to negotiation between the<br \/>\nCompany and the Initial Purchasers.<\/p>\n<\/p>\n<table style=\"width: 100%;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"48%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"1%\"><\/td>\n<td width=\"35%\"><\/td>\n<td width=\"15%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td colspan=\"3\">\n<p>Very truly yours,<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\">\n<p>(Name)<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\">\n<p>(Address)<\/p>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"3\"><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">D-3<\/p>\n<p align=\"center\"><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7322],"corporate_contracts_industries":[],"corporate_contracts_types":[9560,9569],"class_list":["post-41230","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-digital-river-inc","corporate_contracts_types-finance","corporate_contracts_types-finance__notpur"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/41230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=41230"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=41230"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=41230"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=41230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}